{"id":5993,"date":"2025-08-19T16:08:33","date_gmt":"2025-08-19T14:08:33","guid":{"rendered":"https:\/\/hoenle25.akt-digital.de\/?page_id=5993"},"modified":"2025-11-04T16:27:38","modified_gmt":"2025-11-04T15:27:38","slug":"finanzpresse","status":"publish","type":"page","link":"https:\/\/hoenle25.akt-digital.de\/de\/investoren\/finanzpresse\/","title":{"rendered":"Finanzpresse"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_section css=&#8221;.vc_custom_1752143461288{background-color: #F2F4F6 !important;}&#8221;][vc_row][vc_column width=&#8221;1\/2&#8243;]\n<h1 class=\"akt-heading akt-heading--block akt-heading--h1 akt-heading--align-left\">\n            <span class=\"akt-heading__part akt-heading__part--light\">Aktuelle Informationen<\/span>\n                <span class=\"akt-heading__part akt-heading__part--bold\">f\u00fcr Investoren<\/span>\n    <\/h1>[\/vc_column][vc_column width=&#8221;1\/2&#8243;][vc_column_text css=&#8221;&#8221;]Auf dieser Seite finden Sie aktuelle Kapitalmarktmitteilungen und Ad-hoc-Meldungen der Hoenle AG.[\/vc_column_text][\/vc_column][\/vc_row][\/vc_section][vc_section css=&#8221;.vc_custom_1753711788721{background-color: #FFFFFF !important;}&#8221;][vc_row][vc_column]\n<div class=\"akt-tabs-wrapper akt-tabs-wrapper-media\">\n    \n            <div class=\"akt-tabs akt-tabs--style-underline\" id=\"akt-tabs-40908\" data-default-tab=\"0\">\n            \n            <!-- Tab Navigation -->\n            <div class=\"akt-tabs__nav-wrapper\">\n                <div class=\"akt-tabs__nav\" role=\"tablist\" aria-label=\"Content tabs\">\n                                                                    <button \n                            type=\"button\"\n                            class=\"akt-tabs__tab akt-tabs__tab--active\"\n                            id=\"akt-tabs-40908-tab-0\"\n                            role=\"tab\"\n                            aria-selected=\"true\"\n                            aria-controls=\"akt-tabs-40908-panel-0\"\n                            tabindex=\"0\"\n                            data-tab-index=\"0\"\n                                                                                                                                            >\n                            Kapitalmarkt-Mitteilung                        <\/button>\n                                                                    <button \n                            type=\"button\"\n                            class=\"akt-tabs__tab \"\n                            id=\"akt-tabs-40908-tab-1\"\n                            role=\"tab\"\n                            aria-selected=\"false\"\n                            aria-controls=\"akt-tabs-40908-panel-1\"\n                            tabindex=\"-1\"\n                            data-tab-index=\"1\"\n                                                                                                                                            >\n                            Ad-Hoc-Mitteilung                        <\/button>\n                                    <\/div>\n                                    <div class=\"akt-tabs__top-controls\">\n                        <button class=\"akt-tabs__nav-button akt-tabs__nav-button--prev\"\n                                aria-label=\"Previous tab\"\n                                data-prev-title=\"\"\n                                disabled>\n                            <span class=\"akt-tabs__nav-button-icon\">\u2039<\/span>\n                        <\/button>\n                        <div class=\"akt-tabs__counter akt-tabs__counter--top\" aria-live=\"polite\" aria-atomic=\"true\">\n                            1\/2                        <\/div>\n                        <button class=\"akt-tabs__nav-button akt-tabs__nav-button--next\"\n                                aria-label=\"Next tab\"\n                                data-next-title=\"Ad-Hoc-Mitteilung\"\n                                                        >\n                            <span class=\"akt-tabs__nav-button-icon\">\u203a<\/span>\n                        <\/button>\n                    <\/div>\n                            <\/div>\n\n            <!-- Tab Content -->\n            <div class=\"akt-tabs__content\">\n                <div class=\"akt-tabs__panel akt-tabs__panel--active\" role=\"tabpanel\" id=\"-panel-0\" aria-labelledby=\"-tab-0\" data-tab-index=\"0\" data-tab-title=\"Kapitalmarkt-Mitteilung\">[vc_row_inner][vc_column_inner]\n<div class=\"ir-press-links\">\n  <div class=\"akt-row\">\n    <div class=\"akt-col\">\n      <div class=\"akt-col__inner\">\n                  <h2 class=\"ir-press-links__title\">Kapitalmarkt-Mitteilung<\/h2>\n              <\/div>\n    <\/div>\n    <div class=\"akt-col\">\n      <div class=\"akt-col__inner\">\n        <ul class=\"ir-press-links__list\">\n                                    <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">08.Dez..2025<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-news-hoenle-ag-hoenle-gruppe-verbessert-betriebsergebnis-vor-abschreibungen-im-geschaeftsjahr-2024-25-auf-58-mio-eur\/\" title=\"PTA-News: Hoenle AG: Hoenle Gruppe verbessert Betriebsergebnis vor Abschreibungen im Gesch\u00e4ftsjahr 2024\/25 auf 5,8 Mio. EUR\">PTA-News: Hoenle AG: Hoenle Gruppe verbessert Betriebsergebnis vor Abschreibungen im Gesch\u00e4ftsjahr 2024\/25 auf 5,8 Mio. EUR<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">09.Okt..2025<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-afr-hoenle-ag-vorabbekanntmachung-ueber-die-veroeffentlichung-von-finanzberichten-gemaess-%c2%a7%c2%a7-114-117-wphg\/\" title=\"PTA-AFR: Hoenle AG: Vorabbekanntmachung \u00fcber die Ver\u00f6ffentlichung von Finanzberichten gem\u00e4\u00df \u00a7\u00a7 114-117 WpHG\">PTA-AFR: Hoenle AG: Vorabbekanntmachung \u00fcber die Ver\u00f6ffentlichung von Finanzberichten gem\u00e4\u00df \u00a7\u00a7 114-117 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">14.Sep..2025<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-news-dr-hoenle-ag-dr-franz-richter-ersetzt-dr-markus-arendt-im-vorstand-der-hoenle-ag\/\" title=\"PTA-News: Dr. H\u00f6nle AG: Dr. Franz Richter ersetzt Dr. Markus Arendt im Vorstand der Hoenle AG\">PTA-News: Dr. H\u00f6nle AG: Dr. Franz Richter ersetzt Dr. Markus Arendt im Vorstand der Hoenle AG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">07.Aug..2025<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-news-dr-hoenle-ag-hoenle-gruppe-erzielt-nach-neun-monaten-36-mio-euro-ebitda-bei-698-mio-euro-umsatz\/\" title=\"PTA-News: Dr. H\u00f6nle AG: H\u00f6nle Gruppe erzielt nach neun Monaten 3,6 Mio. Euro EBITDA bei 69,8 Mio. Euro Umsatz\">PTA-News: Dr. H\u00f6nle AG: H\u00f6nle Gruppe erzielt nach neun Monaten 3,6 Mio. Euro EBITDA bei 69,8 Mio. Euro Umsatz<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">08.Mai.2025<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-news-dr-hoenle-ag-belebung-der-geschaeftstaetigkeit-im-zweiten-quartal\/\" title=\"PTA-News: Dr. H\u00f6nle AG: Belebung der Gesch\u00e4ftst\u00e4tigkeit im zweiten Quartal\">PTA-News: Dr. H\u00f6nle AG: Belebung der Gesch\u00e4ftst\u00e4tigkeit im zweiten Quartal<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">25.Feb..2025<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-news-dr-hoenle-ag-hoenle-gruppe-startet-planmaessig-in-neues-geschaeftsjahr-und-bestaetigt-ausblick-auf-gesamtjahr\/\" title=\"PTA-News: Dr. H\u00f6nle AG: H\u00f6nle Gruppe startet planm\u00e4\u00dfig in neues Gesch\u00e4ftsjahr und best\u00e4tigt Ausblick auf Gesamtjahr\">PTA-News: Dr. H\u00f6nle AG: H\u00f6nle Gruppe startet planm\u00e4\u00dfig in neues Gesch\u00e4ftsjahr und best\u00e4tigt Ausblick auf Gesamtjahr<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">17.Feb..2025<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-pvr-dr-hoenle-ag-veroeffentlichung-nach-%c2%a7-40-abs-1-wphg-20\/\" title=\"PTA-PVR: Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG\">PTA-PVR: Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">12.Feb..2025<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-hv-dr-hoenle-aktiengesellschaft-einladung-zur-ordentlichen-hauptversammlung-4\/\" title=\"PTA-HV: Dr. H\u00f6nle Aktiengesellschaft: Einladung zur ordentlichen Hauptversammlung\">PTA-HV: Dr. H\u00f6nle Aktiengesellschaft: Einladung zur ordentlichen Hauptversammlung<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">12.Feb..2025<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-hv-dr-hoenle-aktiengesellschaft-einladung-zur-ordentlichen-hauptversammlung-3\/\" title=\"PTA-HV: Dr. H\u00f6nle Aktiengesellschaft: Einladung zur ordentlichen Hauptversammlung\">PTA-HV: Dr. H\u00f6nle Aktiengesellschaft: Einladung zur ordentlichen Hauptversammlung<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">12.Feb..2025<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-pvr-dr-hoenle-ag-veroeffentlichung-nach-%c2%a7-40-abs-1-wphg-18\/\" title=\"PTA-PVR: Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG\">PTA-PVR: Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">12.Feb..2025<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-pvr-dr-hoenle-ag-veroeffentlichung-nach-%c2%a7-40-abs-1-wphg-19\/\" title=\"PTA-PVR: Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG\">PTA-PVR: Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">06.Feb..2025<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-afr-dr-hoenle-ag-vorabbekanntmachung-ueber-die-veroeffentlichung-von-finanzberichten-gemaess-%c2%a7%c2%a7-114-117-wphg-8\/\" title=\"PTA-AFR: Dr. H\u00f6nle AG: Vorabbekanntmachung \u00fcber die Ver\u00f6ffentlichung von Finanzberichten gem\u00e4\u00df \u00a7\u00a7 114-117 WpHG\">PTA-AFR: Dr. H\u00f6nle AG: Vorabbekanntmachung \u00fcber die Ver\u00f6ffentlichung von Finanzberichten gem\u00e4\u00df \u00a7\u00a7 114-117 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">02.Jan..2025<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-pvr-dr-hoenle-ag-veroeffentlichung-nach-%c2%a7-40-abs-1-wphg-17\/\" title=\"PTA-PVR: Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG\">PTA-PVR: Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">02.Jan..2025<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-pvr-dr-hoenle-ag-veroeffentlichung-nach-%c2%a7-40-abs-1-wphg-16\/\" title=\"PTA-PVR: Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG\">PTA-PVR: Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">06.Dez..2024<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-news-dr-hoenle-ag-hoenle-gruppe-erzielt-im-geschaeftsjahr-2023-24-bei-einem-umsatz-von-987-mio-e-ein-ausgeglichenes-operatives-ergebnis\/\" title=\"PTA-News: Dr. H\u00f6nle AG: H\u00f6nle Gruppe erzielt im Gesch\u00e4ftsjahr 2023\/24 bei einem Umsatz von 98,7 Mio. \u20ac ein ausgeglichenes operatives Ergebnis\">PTA-News: Dr. H\u00f6nle AG: H\u00f6nle Gruppe erzielt im Gesch\u00e4ftsjahr 2023\/24 bei einem Umsatz von 98,7 Mio. \u20ac ein ausgeglichenes operatives Ergebnis<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">20.Nov..2024<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-afr-dr-hoenle-ag-vorabbekanntmachung-ueber-die-veroeffentlichung-von-finanzberichten-gemaess-%c2%a7%c2%a7-114-117-wphg-7\/\" title=\"PTA-AFR: Dr. H\u00f6nle AG: Vorabbekanntmachung \u00fcber die Ver\u00f6ffentlichung von Finanzberichten gem\u00e4\u00df \u00a7\u00a7 114-117 WpHG\">PTA-AFR: Dr. H\u00f6nle AG: Vorabbekanntmachung \u00fcber die Ver\u00f6ffentlichung von Finanzberichten gem\u00e4\u00df \u00a7\u00a7 114-117 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">07.Aug..2024<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-pvr-dr-hoenle-ag-veroeffentlichung-nach-%c2%a7-40-abs-1-wphg-15\/\" title=\"PTA-PVR: Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG\">PTA-PVR: Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">07.Aug..2024<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-pvr-dr-hoenle-ag-veroeffentlichung-nach-%c2%a7-40-abs-1-wphg-14\/\" title=\"PTA-PVR: Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG\">PTA-PVR: Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">07.Aug..2024<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-news-dr-hoenle-ag-hoenle-erzielt-in-einem-herausfordernden-marktumfeld-nach-9-monaten-ein-nahezu-ausgeglichenes-betriebsergebnis\/\" title=\"PTA-News: Dr. H\u00f6nle AG: H\u00f6nle erzielt in einem herausfordernden Marktumfeld nach 9 Monaten ein nahezu ausgeglichenes Betriebsergebnis\">PTA-News: Dr. H\u00f6nle AG: H\u00f6nle erzielt in einem herausfordernden Marktumfeld nach 9 Monaten ein nahezu ausgeglichenes Betriebsergebnis<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">06.Aug..2024<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-news-dr-hoenle-ag-robert-stark-wird-neuer-finanzvorstand-der-dr-hoenle-ag\/\" title=\"PTA-News: Dr. H\u00f6nle AG: Robert Stark wird neuer Finanzvorstand der Dr. H\u00f6nle AG\">PTA-News: Dr. H\u00f6nle AG: Robert Stark wird neuer Finanzvorstand der Dr. H\u00f6nle AG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">08.Mai.2024<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-news-dr-hoenle-ag-umsaetze-und-ergebnisse-in-einem-herausfordernden-marktumfeld-im-halbjahr-unter-vorjahr\/\" title=\"PTA-News: Dr. H\u00f6nle AG: Ums\u00e4tze und Ergebnisse in einem herausfordernden Marktumfeld im Halbjahr unter Vorjahr\">PTA-News: Dr. H\u00f6nle AG: Ums\u00e4tze und Ergebnisse in einem herausfordernden Marktumfeld im Halbjahr unter Vorjahr<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">07.Mai.2024<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-news-dr-hoenle-ag-markus-arendt-nimmt-seine-taetigkeit-im-vorstand-der-dr-hoenle-ag-auf\/\" title=\"PTA-News: Dr. H\u00f6nle AG: Markus Arendt nimmt seine T\u00e4tigkeit im Vorstand der Dr. H\u00f6nle AG auf\">PTA-News: Dr. H\u00f6nle AG: Markus Arendt nimmt seine T\u00e4tigkeit im Vorstand der Dr. H\u00f6nle AG auf<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">18.Apr..2024<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-afr-dr-hoenle-ag-vorabbekanntmachung-ueber-die-veroeffentlichung-von-finanzberichten-gemaess-%c2%a7%c2%a7-114-117-wphg-6\/\" title=\"PTA-AFR: Dr. H\u00f6nle AG: Vorabbekanntmachung \u00fcber die Ver\u00f6ffentlichung von Finanzberichten gem\u00e4\u00df \u00a7\u00a7 114-117 WpHG\">PTA-AFR: Dr. H\u00f6nle AG: Vorabbekanntmachung \u00fcber die Ver\u00f6ffentlichung von Finanzberichten gem\u00e4\u00df \u00a7\u00a7 114-117 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">27.Feb..2024<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-pvr-dr-hoenle-ag-mitteilung-ueber-mitteilungspflichten-fuer-inhaber-wesentlicher-beteiligungen-gemaess-%c2%a7-43-wphg-4\/\" title=\"PTA-PVR: Dr. H\u00f6nle AG: Mitteilung \u00fcber Mitteilungspflichten f\u00fcr Inhaber wesentlicher Beteiligungen gem\u00e4\u00df \u00a7 43 WpHG\">PTA-PVR: Dr. H\u00f6nle AG: Mitteilung \u00fcber Mitteilungspflichten f\u00fcr Inhaber wesentlicher Beteiligungen gem\u00e4\u00df \u00a7 43 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">27.Feb..2024<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-pvr-dr-hoenle-ag-veroeffentlichung-nach-%c2%a7-40-abs-1-wphg-13\/\" title=\"PTA-PVR: Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG\">PTA-PVR: Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">26.Feb..2024<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-news-dr-hoenle-ag-hoenle-gruppe-startet-verhalten-ins-neue-geschaeftsjahr-und-bestaetigt-ausblick-auf-das-gesamtjahr\/\" title=\"PTA-News: Dr. H\u00f6nle AG: H\u00f6nle Gruppe startet verhalten ins neue Gesch\u00e4ftsjahr und best\u00e4tigt Ausblick auf das Gesamtjahr\">PTA-News: Dr. H\u00f6nle AG: H\u00f6nle Gruppe startet verhalten ins neue Gesch\u00e4ftsjahr und best\u00e4tigt Ausblick auf das Gesamtjahr<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">23.Feb..2024<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-pvr-dr-hoenle-ag-veroeffentlichung-nach-%c2%a7-40-abs-1-wphg-12\/\" title=\"PTA-PVR: Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG\">PTA-PVR: Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">23.Feb..2024<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-pvr-dr-hoenle-ag-veroeffentlichung-nach-%c2%a7-40-abs-1-wphg-11\/\" title=\"PTA-PVR: Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG\">PTA-PVR: Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">22.Feb..2024<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-dd-dr-hoenle-ag-mitteilung-ueber-eigengeschaefte-von-fuehrungskraeften-gemaess-artikel-19-mar-12\/\" title=\"PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem\u00e4\u00df Artikel 19 MAR\">PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem\u00e4\u00df Artikel 19 MAR<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">22.Feb..2024<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-dd-dr-hoenle-ag-mitteilung-ueber-eigengeschaefte-von-fuehrungskraeften-gemaess-artikel-19-mar-11\/\" title=\"PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem\u00e4\u00df Artikel 19 MAR\">PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem\u00e4\u00df Artikel 19 MAR<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">22.Feb..2024<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-dd-dr-hoenle-ag-mitteilung-ueber-eigengeschaefte-von-fuehrungskraeften-gemaess-artikel-19-mar-10\/\" title=\"PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem\u00e4\u00df Artikel 19 MAR\">PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem\u00e4\u00df Artikel 19 MAR<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">15.Feb..2024<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-pvr-dr-hoenle-ag-veroeffentlichung-nach-%c2%a7-40-abs-1-wphg-10\/\" title=\"PTA-PVR: Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG\">PTA-PVR: Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">08.Feb..2024<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-hv-dr-hoenle-aktiengesellschaft-einladung-zur-ordentlichen-hauptversammlung-2\/\" title=\"PTA-HV: Dr. H\u00f6nle Aktiengesellschaft: Einladung zur ordentlichen Hauptversammlung\">PTA-HV: Dr. H\u00f6nle Aktiengesellschaft: Einladung zur ordentlichen Hauptversammlung<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">07.Dez..2023<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-news-dr-hoenle-ag-hoenle-gruppe-erwirtschaftet-bereinigtes-betriebsergebnis-von-69-mio-e-im-geschaeftsjahr-2022-2023\/\" title=\"PTA-News: Dr. H\u00f6nle AG: H\u00f6nle Gruppe erwirtschaftet bereinigtes Betriebsergebnis von 6,9 Mio. \u20ac im Gesch\u00e4ftsjahr 2022\/2023\">PTA-News: Dr. H\u00f6nle AG: H\u00f6nle Gruppe erwirtschaftet bereinigtes Betriebsergebnis von 6,9 Mio. \u20ac im Gesch\u00e4ftsjahr 2022\/2023<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">03.Nov..2023<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-afr-dr-hoenle-ag-vorabbekanntmachung-ueber-die-veroeffentlichung-von-finanzberichten-gemaess-%c2%a7%c2%a7-114-117-wphg-5\/\" title=\"PTA-AFR: Dr. H\u00f6nle AG: Vorabbekanntmachung \u00fcber die Ver\u00f6ffentlichung von Finanzberichten gem\u00e4\u00df \u00a7\u00a7 114-117 WpHG\">PTA-AFR: Dr. H\u00f6nle AG: Vorabbekanntmachung \u00fcber die Ver\u00f6ffentlichung von Finanzberichten gem\u00e4\u00df \u00a7\u00a7 114-117 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">20.Okt..2023<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-news-dr-hoenle-ag-dr-markus-arendt-wird-neuer-vorstand-der-dr-hoenle-ag\/\" title=\"PTA-News: Dr. H\u00f6nle AG: Dr. Markus Arendt wird neuer Vorstand der Dr. H\u00f6nle AG\">PTA-News: Dr. H\u00f6nle AG: Dr. Markus Arendt wird neuer Vorstand der Dr. H\u00f6nle AG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">07.Aug..2023<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-news-dr-hoenle-ag-hoenle-erwirtschaftet-in-neun-monaten-bereinigtes-betriebsergebnis-von-50-mio-e\/\" title=\"PTA-News: Dr. H\u00f6nle AG: H\u00f6nle erwirtschaftet in neun Monaten bereinigtes Betriebsergebnis von 5,0 Mio. \u20ac\">PTA-News: Dr. H\u00f6nle AG: H\u00f6nle erwirtschaftet in neun Monaten bereinigtes Betriebsergebnis von 5,0 Mio. \u20ac<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">23.Juni.2023<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-pvr-dr-hoenle-ag-mitteilung-ueber-mitteilungspflichten-fuer-inhaber-wesentlicher-beteiligungen-gemaess-%c2%a7-43-wphg-3\/\" title=\"PTA-PVR: Dr. H\u00f6nle AG: Mitteilung \u00fcber Mitteilungspflichten f\u00fcr Inhaber wesentlicher Beteiligungen gem\u00e4\u00df \u00a7 43 WpHG\">PTA-PVR: Dr. H\u00f6nle AG: Mitteilung \u00fcber Mitteilungspflichten f\u00fcr Inhaber wesentlicher Beteiligungen gem\u00e4\u00df \u00a7 43 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">12.Juni.2023<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-dd-dr-hoenle-ag-mitteilung-ueber-eigengeschaefte-von-fuehrungskraeften-gemaess-artikel-19-mar-9\/\" title=\"PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem\u00e4\u00df Artikel 19 MAR\">PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem\u00e4\u00df Artikel 19 MAR<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">07.Juni.2023<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-dd-dr-hoenle-ag-mitteilung-ueber-eigengeschaefte-von-fuehrungskraeften-gemaess-artikel-19-mar-8\/\" title=\"PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem\u00e4\u00df Artikel 19 MAR\">PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem\u00e4\u00df Artikel 19 MAR<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">07.Juni.2023<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-dd-dr-hoenle-ag-mitteilung-ueber-eigengeschaefte-von-fuehrungskraeften-gemaess-artikel-19-mar-7\/\" title=\"PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem\u00e4\u00df Artikel 19 MAR\">PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem\u00e4\u00df Artikel 19 MAR<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">07.Juni.2023<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-dd-dr-hoenle-ag-mitteilung-ueber-eigengeschaefte-von-fuehrungskraeften-gemaess-artikel-19-mar-6\/\" title=\"PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem\u00e4\u00df Artikel 19 MAR\">PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem\u00e4\u00df Artikel 19 MAR<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">07.Juni.2023<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-dd-dr-hoenle-ag-mitteilung-ueber-eigengeschaefte-von-fuehrungskraeften-gemaess-artikel-19-mar-5\/\" title=\"PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem\u00e4\u00df Artikel 19 MAR\">PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem\u00e4\u00df Artikel 19 MAR<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">07.Juni.2023<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-pvr-dr-hoenle-ag-veroeffentlichung-nach-%c2%a7-40-abs-1-wphg-9\/\" title=\"PTA-PVR: Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG\">PTA-PVR: Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">12.Mai.2023<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-news-dr-hoenle-ag-hoenle-erwirtschaftet-im-halbjahr-betriebsergebnis-von-37-mio-e\/\" title=\"PTA-News: Dr. H\u00f6nle AG: H\u00f6nle erwirtschaftet im Halbjahr Betriebsergebnis von 3,7 Mio. \u20ac\">PTA-News: Dr. H\u00f6nle AG: H\u00f6nle erwirtschaftet im Halbjahr Betriebsergebnis von 3,7 Mio. \u20ac<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">25.Apr..2023<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-news-dr-hoenle-ag-wechsel-an-der-spitze-der-dr-hoenle-ag-dr-franz-richter-wird-neuer-vorstandsvorsitzender\/\" title=\"PTA-News: Dr. H\u00f6nle AG: Wechsel an der Spitze der Dr. H\u00f6nle AG: Dr. Franz Richter wird neuer Vorstandsvorsitzender\">PTA-News: Dr. H\u00f6nle AG: Wechsel an der Spitze der Dr. H\u00f6nle AG: Dr. Franz Richter wird neuer Vorstandsvorsitzender<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">31.M\u00e4rz.2023<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-news-dr-hoenle-ag-dr-franz-richter-ist-neuer-aufsichtsratsvorsitzender-der-dr-hoenle-ag\/\" title=\"PTA-News: Dr. H\u00f6nle AG: Dr. Franz Richter ist neuer Aufsichtsratsvorsitzender der Dr. H\u00f6nle AG\">PTA-News: Dr. H\u00f6nle AG: Dr. Franz Richter ist neuer Aufsichtsratsvorsitzender der Dr. H\u00f6nle AG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">15.Feb..2023<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-dd-dr-hoenle-ag-mitteilung-ueber-eigengeschaefte-von-fuehrungskraeften-gemaess-artikel-19-mar-4\/\" title=\"PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem\u00e4\u00df Artikel 19 MAR\">PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem\u00e4\u00df Artikel 19 MAR<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">13.Feb..2023<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-hv-dr-hoenle-aktiengesellschaft-einladung-zur-ordentlichen-hauptversammlung\/\" title=\"PTA-HV: Dr. H\u00f6nle Aktiengesellschaft: Einladung zur ordentlichen Hauptversammlung\">PTA-HV: Dr. H\u00f6nle Aktiengesellschaft: Einladung zur ordentlichen Hauptversammlung<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">09.Feb..2023<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-pvr-dr-hoenle-ag-mitteilung-ueber-mitteilungspflichten-fuer-inhaber-wesentlicher-beteiligungen-gemaess-%c2%a7-43-wphg-2\/\" title=\"PTA-PVR: Dr. H\u00f6nle AG: Mitteilung \u00fcber Mitteilungspflichten f\u00fcr Inhaber wesentlicher Beteiligungen gem\u00e4\u00df \u00a7 43 WpHG\">PTA-PVR: Dr. H\u00f6nle AG: Mitteilung \u00fcber Mitteilungspflichten f\u00fcr Inhaber wesentlicher Beteiligungen gem\u00e4\u00df \u00a7 43 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">17.Jan..2023<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-pvr-dr-hoenle-ag-veroeffentlichung-nach-%c2%a7-40-abs-1-wphg-8\/\" title=\"PTA-PVR: Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG\">PTA-PVR: Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">15.Dez..2022<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-news-dr-hoenle-ag-geplanter-wechsel-im-aufsichtsrat-der-dr-hoenle-ag\/\" title=\"PTA-News: Dr. H\u00f6nle AG: Geplanter Wechsel im Aufsichtsrat der Dr. H\u00f6nle AG\">PTA-News: Dr. H\u00f6nle AG: Geplanter Wechsel im Aufsichtsrat der Dr. H\u00f6nle AG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">19.Okt..2022<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-afr-dr-hoenle-ag-vorabbekanntmachung-ueber-die-veroeffentlichung-von-finanzberichten-gemaess-%c2%a7%c2%a7-114-117-wphg-4\/\" title=\"PTA-AFR: Dr. H\u00f6nle AG: Vorabbekanntmachung \u00fcber die Ver\u00f6ffentlichung von Finanzberichten gem\u00e4\u00df \u00a7\u00a7 114-117 WpHG\">PTA-AFR: Dr. H\u00f6nle AG: Vorabbekanntmachung \u00fcber die Ver\u00f6ffentlichung von Finanzberichten gem\u00e4\u00df \u00a7\u00a7 114-117 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">02.Sep..2022<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-pvr-dr-hoenle-ag-veroeffentlichung-nach-%c2%a7-40-abs-1-wphg-7\/\" title=\"PTA-PVR : Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG\">PTA-PVR : Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">02.Sep..2022<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-dd-dr-hoenle-ag-mitteilung-ueber-eigengeschaefte-von-fuehrungskraeften-gemaess-artikel-19-mar-3\/\" title=\"PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem\u00e4\u00df Artikel 19 MAR\">PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem\u00e4\u00df Artikel 19 MAR<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">05.Aug..2022<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-news-dr-hoenle-ag-hoenle-gruppe-steigert-umsatz-in-9-monaten-um-12\/\" title=\"PTA-News: Dr. H\u00f6nle AG: H\u00f6nle Gruppe steigert Umsatz in 9 Monaten um 12 %\">PTA-News: Dr. H\u00f6nle AG: H\u00f6nle Gruppe steigert Umsatz in 9 Monaten um 12 %<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">16.Mai.2022<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-news-dr-hoenle-ag-neustrukturierung-des-vorstands-der-dr-hoenle-ag\/\" title=\"PTA-News: Dr. H\u00f6nle AG: Neustrukturierung des Vorstands der Dr. H\u00f6nle AG\">PTA-News: Dr. H\u00f6nle AG: Neustrukturierung des Vorstands der Dr. H\u00f6nle AG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">12.Mai.2022<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-news-dr-hoenle-ag-hoenle-steigert-betriebsergebnis-im-halbjahr-um-14-auf-77-mio-eur\/\" title=\"PTA-News: Dr. H\u00f6nle AG: H\u00f6nle steigert Betriebsergebnis im Halbjahr um 14 % auf 7,7 Mio. Eur\">PTA-News: Dr. H\u00f6nle AG: H\u00f6nle steigert Betriebsergebnis im Halbjahr um 14 % auf 7,7 Mio. Eur<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">11.Mai.2022<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-afr-dr-hoenle-ag-vorabbekanntmachung-ueber-die-veroeffentlichung-von-finanzberichten-gemaess-%c2%a7%c2%a7-114-117-wphg-3\/\" title=\"PTA-AFR: Dr. H\u00f6nle AG: Vorabbekanntmachung \u00fcber die Ver\u00f6ffentlichung von Finanzberichten gem\u00e4\u00df \u00a7\u00a7 114-117 WpHG\">PTA-AFR: Dr. H\u00f6nle AG: Vorabbekanntmachung \u00fcber die Ver\u00f6ffentlichung von Finanzberichten gem\u00e4\u00df \u00a7\u00a7 114-117 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">31.M\u00e4rz.2022<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-dd-dr-hoenle-ag-mitteilung-ueber-eigengeschaefte-von-fuehrungskraeften-gemaess-artikel-19-mar-2\/\" title=\"PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem\u00e4\u00df Artikel 19 MAR\">PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem\u00e4\u00df Artikel 19 MAR<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">24.M\u00e4rz.2022<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-pvr-dr-hoenle-ag-mitteilung-ueber-mitteilungspflichten-fuer-inhaber-wesentlicher-beteiligungen-gemaess-%c2%a7-43-wphg\/\" title=\"PTA-PVR: Dr. H\u00f6nle AG: Mitteilung \u00fcber Mitteilungspflichten f\u00fcr Inhaber wesentlicher Beteiligungen gem\u00e4\u00df \u00a7 43 WpHG\">PTA-PVR: Dr. H\u00f6nle AG: Mitteilung \u00fcber Mitteilungspflichten f\u00fcr Inhaber wesentlicher Beteiligungen gem\u00e4\u00df \u00a7 43 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">23.M\u00e4rz.2022<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-pvr-dr-hoenle-ag-korrektur-einer-veroeffentlichung-gem-%c2%a7-40-abs-1-wphg-vom-28-02-2022-2\/\" title=\"PTA-PVR : Dr. H\u00f6nle AG: Korrektur einer Ver\u00f6ffentlichung gem. \u00a7 40 Abs. 1 WpHG vom 28.02.2022\">PTA-PVR : Dr. H\u00f6nle AG: Korrektur einer Ver\u00f6ffentlichung gem. \u00a7 40 Abs. 1 WpHG vom 28.02.2022<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">28.Feb..2022<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-pvr-dr-hoenle-ag-korrektur-einer-veroeffentlichung-gem-%c2%a7-40-abs-1-wphg-vom-28-02-2022\/\" title=\"PTA-PVR : Dr. H\u00f6nle AG: Korrektur einer Ver\u00f6ffentlichung gem. \u00a7 40 Abs. 1 WpHG vom 28.02.2022\">PTA-PVR : Dr. H\u00f6nle AG: Korrektur einer Ver\u00f6ffentlichung gem. \u00a7 40 Abs. 1 WpHG vom 28.02.2022<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">28.Feb..2022<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-pvr-dr-hoenle-ag-veroeffentlichung-nach-%c2%a7-40-abs-1-wphg-6\/\" title=\"PTA-PVR : Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG\">PTA-PVR : Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">24.Feb..2022<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-pvr-dr-hoenle-ag-veroeffentlichung-nach-%c2%a7-40-abs-1-wphg-5\/\" title=\"PTA-PVR : Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG\">PTA-PVR : Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">22.Feb..2022<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-news-dr-hoenle-ag-hoenle-steigert-betriebsergebnis-im-ersten-quartal-um-1136-auf-45-mio-e\/\" title=\"PTA-News: Dr. H\u00f6nle AG: H\u00f6nle steigert Betriebsergebnis im ersten Quartal um 113,6 % auf 4,5 Mio. \u20ac\">PTA-News: Dr. H\u00f6nle AG: H\u00f6nle steigert Betriebsergebnis im ersten Quartal um 113,6 % auf 4,5 Mio. \u20ac<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">14.Feb..2022<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-hv-dr-hoenle-aktiengesellschaft-einladung-zur-ordentlichen-virtuellen-hauptversammlung-2\/\" title=\"PTA-HV: Dr. H\u00f6nle Aktiengesellschaft: Einladung zur ordentlichen (virtuellen) Hauptversammlung\">PTA-HV: Dr. H\u00f6nle Aktiengesellschaft: Einladung zur ordentlichen (virtuellen) Hauptversammlung<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">26.Okt..2021<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-dd-dr-hoenle-ag-mitteilung-ueber-eigengeschaefte-von-fuehrungskraeften-gem-art-19-mar-5\/\" title=\"PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem. Art. 19 MAR\">PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem. Art. 19 MAR<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">03.Sep..2021<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-dd-dr-hoenle-ag-mitteilung-ueber-eigengeschaefte-von-fuehrungskraeften-gem-art-19-mar-4\/\" title=\"PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem. Art. 19 MAR\">PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem. Art. 19 MAR<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">30.Aug..2021<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-dd-dr-hoenle-ag-mitteilung-ueber-eigengeschaefte-von-fuehrungskraeften-gem-art-19-mar-3\/\" title=\"PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem. Art. 19 MAR\">PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem. Art. 19 MAR<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">30.Aug..2021<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-dd-dr-hoenle-ag-mitteilung-ueber-eigengeschaefte-von-fuehrungskraeften-gem-art-19-mar-2\/\" title=\"PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem. Art. 19 MAR\">PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem. Art. 19 MAR<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">25.Aug..2021<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-dd-dr-hoenle-ag-mitteilung-ueber-eigengeschaefte-von-fuehrungskraeften-gem-art-19-mar\/\" title=\"PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem. Art. 19 MAR\">PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem. Art. 19 MAR<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">06.Aug..2021<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-news-dr-hoenle-ag-umsatz-steigt-im-9-monatszeitraum-um-184-auf-849-mio-euro\/\" title=\"PTA-News: Dr. H\u00f6nle AG: Umsatz steigt im 9-Monatszeitraum um 18,4 % auf 84,9 Mio. Euro\">PTA-News: Dr. H\u00f6nle AG: Umsatz steigt im 9-Monatszeitraum um 18,4 % auf 84,9 Mio. Euro<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">01.Juli.2021<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-dd-dr-hoenle-ag-mitteilung-ueber-eigengeschaefte-von-fuehrungskraeften-gemaess-artikel-19-mar\/\" title=\"PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem\u00e4\u00df Artikel 19 MAR\">PTA-DD: Dr. H\u00f6nle AG: Mitteilung \u00fcber Eigengesch\u00e4fte von F\u00fchrungskr\u00e4ften gem\u00e4\u00df Artikel 19 MAR<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">11.Juni.2021<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-pvr-dr-hoenle-ag-veroeffentlichung-nach-%c2%a7-40-abs-1-wphg-4\/\" title=\"PTA-PVR : Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG\">PTA-PVR : Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">12.Mai.2021<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-news-dr-hoenle-ag-hoenle-steigert-betriebsergebnis-im-halbjahr-um-164-auf-67-mio-euro\/\" title=\"PTA-News: Dr. H\u00f6nle AG: H\u00f6nle steigert Betriebsergebnis im Halbjahr um 16,4 % auf 6,7 Mio. Euro\">PTA-News: Dr. H\u00f6nle AG: H\u00f6nle steigert Betriebsergebnis im Halbjahr um 16,4 % auf 6,7 Mio. Euro<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">22.Feb..2021<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-news-dr-hoenle-ag-hoenle-erzielt-im-ersten-quartal-einen-umsatz-von-267-mio-euro-und-ein-betriebsergebnis-von-21-mio-euro\/\" title=\"PTA-News: Dr. H\u00f6nle AG: H\u00f6nle erzielt im ersten Quartal einen Umsatz von 26,7 Mio. Euro und ein Betriebsergebnis von 2,1 Mio. Euro\">PTA-News: Dr. H\u00f6nle AG: H\u00f6nle erzielt im ersten Quartal einen Umsatz von 26,7 Mio. Euro und ein Betriebsergebnis von 2,1 Mio. Euro<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">12.Feb..2021<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-afr-dr-hoenle-ag-vorabbekanntmachung-ueber-die-veroeffentlichung-von-finanzberichten-gemaess-%c2%a7%c2%a7-114-117-wphg-2\/\" title=\"PTA-AFR: Dr. H\u00f6nle AG: Vorabbekanntmachung \u00fcber die Ver\u00f6ffentlichung von Finanzberichten gem\u00e4\u00df \u00a7\u00a7 114-117 WpHG\">PTA-AFR: Dr. H\u00f6nle AG: Vorabbekanntmachung \u00fcber die Ver\u00f6ffentlichung von Finanzberichten gem\u00e4\u00df \u00a7\u00a7 114-117 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">10.Feb..2021<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-hv-dr-hoenle-aktiengesellschaft-einladung-zur-ordentlichen-virtuellen-hauptversammlung\/\" title=\"PTA-HV: Dr. H\u00f6nle Aktiengesellschaft: Einladung zur ordentlichen (virtuellen) Hauptversammlung\">PTA-HV: Dr. H\u00f6nle Aktiengesellschaft: Einladung zur ordentlichen (virtuellen) Hauptversammlung<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">02.Dez..2020<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-news-dr-hoenle-ag-hoenle-gruppe-erwirtschaftet-betriebsergebnis-von-81-mio-euro\/\" title=\"PTA-News: Dr. H\u00f6nle AG: H\u00f6nle Gruppe erwirtschaftet Betriebsergebnis von 8,1 Mio. Euro\">PTA-News: Dr. H\u00f6nle AG: H\u00f6nle Gruppe erwirtschaftet Betriebsergebnis von 8,1 Mio. Euro<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">04.Sep..2020<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-pvr-dr-hoenle-ag-veroeffentlichung-nach-%c2%a7-40-abs-1-wphg-3\/\" title=\"PTA-PVR : Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG\">PTA-PVR : Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">01.Sep..2020<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-pvr-dr-hoenle-ag-veroeffentlichung-nach-%c2%a7-40-abs-1-wphg-2\/\" title=\"PTA-PVR : Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG\">PTA-PVR : Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">01.Sep..2020<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-nvr-dr-hoenle-ag-veroeffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-41-wphg\/\" title=\"PTA-NVR: Dr. H\u00f6nle AG: Ver\u00f6ffentlichung der Gesamtzahl der Stimmrechte nach \u00a7 41 WpHG\">PTA-NVR: Dr. H\u00f6nle AG: Ver\u00f6ffentlichung der Gesamtzahl der Stimmrechte nach \u00a7 41 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">18.Aug..2020<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-news-dr-hoenle-ag-uebernahme-im-bereich-life-science\/\" title=\"PTA-News: Dr. H\u00f6nle AG: \u00dcbernahme im Bereich Life Science\">PTA-News: Dr. H\u00f6nle AG: \u00dcbernahme im Bereich Life Science<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">07.Aug..2020<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-news-dr-hoenle-ag-hoenle-erzielt-betriebsergebnis-von-63-mio-euro\/\" title=\"PTA-News: Dr. H\u00f6nle AG: H\u00f6nle erzielt Betriebsergebnis von 6,3 Mio. Euro\">PTA-News: Dr. H\u00f6nle AG: H\u00f6nle erzielt Betriebsergebnis von 6,3 Mio. Euro<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">09.Juli.2020<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-pvr-dr-hoenle-ag-veroeffentlichung-nach-%c2%a7-40-abs-1-wphg\/\" title=\"PTA-PVR : Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG\">PTA-PVR : Dr. H\u00f6nle AG: Ver\u00f6ffentlichung nach \u00a7 40 Abs. 1 WpHG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">15.Mai.2020<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-news-dr-hoenle-ag-hoenle-gruppe-erwirtschaftet-betriebsergebnis-von-58-mio-euro\/\" title=\"PTA-News: Dr. H\u00f6nle AG: H\u00f6nle Gruppe erwirtschaftet Betriebsergebnis von 5,8 Mio. Euro\">PTA-News: Dr. H\u00f6nle AG: H\u00f6nle Gruppe erwirtschaftet Betriebsergebnis von 5,8 Mio. Euro<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">09.Jan..2020<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-afr-dr-hoenle-ag-vorabbekanntmachung-ueber-die-veroeffentlichung-von-finanzberichten-gemaess-%c2%a7%c2%a7-114-117-wphg\/\" title=\"PTA-AFR: Dr. H\u00f6nle AG: Vorabbekanntmachung \u00fcber die Ver\u00f6ffentlichung von Finanzberichten gem\u00e4\u00df \u00a7\u00a7 114-117 WpHG\">PTA-AFR: Dr. H\u00f6nle AG: Vorabbekanntmachung \u00fcber die Ver\u00f6ffentlichung von Finanzberichten gem\u00e4\u00df \u00a7\u00a7 114-117 WpHG<\/a>\n              <\/li>\n                             <\/ul>\n      <\/div>\n    <\/div>\n  <\/div>\n<\/div>\n[\/vc_column_inner][\/vc_row_inner]<\/div><div class=\"akt-tabs__panel\" role=\"tabpanel\" id=\"-panel-1\" aria-labelledby=\"-tab-1\" data-tab-index=\"1\" hidden data-tab-title=\"Ad-Hoc-Mitteilung\">[vc_row_inner][vc_column_inner]\n<div class=\"ir-press-links\">\n  <div class=\"akt-row\">\n    <div class=\"akt-col\">\n      <div class=\"akt-col__inner\">\n                  <h2 class=\"ir-press-links__title\">Ad-Hoc-Mitteilung<\/h2>\n              <\/div>\n    <\/div>\n    <div class=\"akt-col\">\n      <div class=\"akt-col__inner\">\n        <ul class=\"ir-press-links__list\">\n                                    <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">14.Sep..2025<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-adhoc-dr-hoenle-ag-dr-markus-arendt-verlaesst-den-vorstand-der-hoenle-ag\/\" title=\"PTA-Adhoc: Dr. H\u00f6nle AG: Dr. Markus Arendt verl\u00e4sst den Vorstand der Hoenle AG\">PTA-Adhoc: Dr. H\u00f6nle AG: Dr. Markus Arendt verl\u00e4sst den Vorstand der Hoenle AG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">05.Aug..2025<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-adhoc-dr-hoenle-ag-hoenle-gruppe-passt-prognose-fuer-geschaeftsjahr-2024-25-an\/\" title=\"PTA-Adhoc: Dr. H\u00f6nle AG: H\u00f6nle Gruppe passt Prognose f\u00fcr Gesch\u00e4ftsjahr 2024\/25 an\">PTA-Adhoc: Dr. H\u00f6nle AG: H\u00f6nle Gruppe passt Prognose f\u00fcr Gesch\u00e4ftsjahr 2024\/25 an<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">21.Nov..2024<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-adhoc-dr-hoenle-ag-hoenle-gruppe-bestaetigt-positives-operatives-ergebnis-fuer-geschaeftsjahr-2023-24-sondereffekte-belasten-jedoch-ebit\/\" title=\"PTA-Adhoc: Dr. H\u00f6nle AG: H\u00f6nle Gruppe best\u00e4tigt positives operatives Ergebnis f\u00fcr Gesch\u00e4ftsjahr 2023\/24, Sondereffekte belasten jedoch EBIT\">PTA-Adhoc: Dr. H\u00f6nle AG: H\u00f6nle Gruppe best\u00e4tigt positives operatives Ergebnis f\u00fcr Gesch\u00e4ftsjahr 2023\/24, Sondereffekte belasten jedoch EBIT<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">30.Apr..2024<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-adhoc-dr-hoenle-ag-anpassung-des-ausblicks-fuer-das-geschaeftsjahr-2023-24\/\" title=\"PTA-Adhoc: Dr. H\u00f6nle AG: Anpassung des Ausblicks f\u00fcr das Gesch\u00e4ftsjahr 2023\/24\">PTA-Adhoc: Dr. H\u00f6nle AG: Anpassung des Ausblicks f\u00fcr das Gesch\u00e4ftsjahr 2023\/24<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">09.Feb..2024<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-adhoc-dr-hoenle-ag-hoenle-gruppe-erwartet-umsatz-und-ergebnisrueckgang-im-q1-und-bestaetigt-ausblick-auf-das-gesamtjahr\/\" title=\"PTA-Adhoc: Dr. H\u00f6nle AG: H\u00f6nle Gruppe erwartet Umsatz- und Ergebnisr\u00fcckgang im Q1 und best\u00e4tigt Ausblick auf das Gesamtjahr\">PTA-Adhoc: Dr. H\u00f6nle AG: H\u00f6nle Gruppe erwartet Umsatz- und Ergebnisr\u00fcckgang im Q1 und best\u00e4tigt Ausblick auf das Gesamtjahr<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">05.Dez..2023<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-adhoc-dr-hoenle-ag-hoenle-gruppe-passt-prognose-fuer-geschaeftsjahr-2022-2023-an-und-gibt-ausblick-auf-geschaeftsjahr-2023-2024\/\" title=\"PTA-Adhoc: Dr. H\u00f6nle AG: H\u00f6nle Gruppe passt Prognose f\u00fcr Gesch\u00e4ftsjahr 2022\/2023 an und gibt Ausblick auf Gesch\u00e4ftsjahr 2023\/2024\">PTA-Adhoc: Dr. H\u00f6nle AG: H\u00f6nle Gruppe passt Prognose f\u00fcr Gesch\u00e4ftsjahr 2022\/2023 an und gibt Ausblick auf Gesch\u00e4ftsjahr 2023\/2024<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">20.Okt..2023<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-adhoc-dr-hoenle-ag-dr-markus-arendt-wird-neuer-vorstand-der-dr-hoenle-ag\/\" title=\"PTA-Adhoc: Dr. H\u00f6nle AG: Dr. Markus Arendt wird neuer Vorstand der Dr. H\u00f6nle AG\">PTA-Adhoc: Dr. H\u00f6nle AG: Dr. Markus Arendt wird neuer Vorstand der Dr. H\u00f6nle AG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">01.Juni.2023<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-adhoc-dr-hoenle-ag-neueinschaetzung-der-geschaeftslage-und-anpassung-des-ausblicks-fuer-das-geschaeftsjahr-2022-2023\/\" title=\"PTA-Adhoc: Dr. H\u00f6nle AG: Neueinsch\u00e4tzung der Gesch\u00e4ftslage und Anpassung des Ausblicks f\u00fcr das Gesch\u00e4ftsjahr 2022\/2023\">PTA-Adhoc: Dr. H\u00f6nle AG: Neueinsch\u00e4tzung der Gesch\u00e4ftslage und Anpassung des Ausblicks f\u00fcr das Gesch\u00e4ftsjahr 2022\/2023<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">25.Apr..2023<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-adhoc-dr-hoenle-ag-dr-franz-richter-wird-vorstandsvorsitzender-der-dr-hoenle-ag\/\" title=\"PTA-Adhoc: Dr. H\u00f6nle AG: Dr. Franz Richter wird Vorstandsvorsitzender der Dr. H\u00f6nle AG\">PTA-Adhoc: Dr. H\u00f6nle AG: Dr. Franz Richter wird Vorstandsvorsitzender der Dr. H\u00f6nle AG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">20.Feb..2023<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-adhoc-dr-hoenle-ag-hoenle-gruppe-erwirtschaftet-im-ersten-quartal-betriebsergebnis-von-27-mio-e-und-bestaetigt-jahresprognose\/\" title=\"PTA-Adhoc: Dr. H\u00f6nle AG: H\u00f6nle Gruppe erwirtschaftet im ersten Quartal Betriebsergebnis von 2,7 Mio. \u20ac und best\u00e4tigt Jahresprognose\">PTA-Adhoc: Dr. H\u00f6nle AG: H\u00f6nle Gruppe erwirtschaftet im ersten Quartal Betriebsergebnis von 2,7 Mio. \u20ac und best\u00e4tigt Jahresprognose<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">21.Dez..2022<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-adhoc-dr-hoenle-ag-sondereffekte-belasten-ergebnis-im-geschaeftsjahr-2021-2022\/\" title=\"PTA-Adhoc: Dr. H\u00f6nle AG: Sondereffekte belasten Ergebnis im Gesch\u00e4ftsjahr 2021\/2022\">PTA-Adhoc: Dr. H\u00f6nle AG: Sondereffekte belasten Ergebnis im Gesch\u00e4ftsjahr 2021\/2022<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">12.Dez..2022<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-adhoc-dr-hoenle-ag-hoenle-verkauft-saemtliche-anteile-an-der-raesch-quarz-germany-gmbh-ilmenau\/\" title=\"PTA-Adhoc: Dr. H\u00f6nle AG: H\u00f6nle verkauft s\u00e4mtliche Anteile an der Raesch Quarz (Germany) GmbH, Ilmenau\">PTA-Adhoc: Dr. H\u00f6nle AG: H\u00f6nle verkauft s\u00e4mtliche Anteile an der Raesch Quarz (Germany) GmbH, Ilmenau<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">02.Dez..2022<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-adhoc-dr-hoenle-ag-nachlassender-markt-fuer-luftentkeimungsgeraete-fuehrt-zur-wertberichtigung-von-vorraeten-bei-hoenle\/\" title=\"PTA-Adhoc: Dr. H\u00f6nle AG: Nachlassender Markt f\u00fcr Luftentkeimungsger\u00e4te f\u00fchrt zur Wertberichtigung von Vorr\u00e4ten bei H\u00f6nle\">PTA-Adhoc: Dr. H\u00f6nle AG: Nachlassender Markt f\u00fcr Luftentkeimungsger\u00e4te f\u00fchrt zur Wertberichtigung von Vorr\u00e4ten bei H\u00f6nle<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">02.Nov..2022<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-adhoc-dr-hoenle-ag-einleitung-von-restrukturierungsmassnahmen-bei-der-raesch-quarz-germany-gmbh-ilmenau\/\" title=\"PTA-Adhoc: Dr. H\u00f6nle AG: Einleitung von Restrukturierungsma\u00dfnahmen bei der Raesch Quarz (Germany) GmbH, Ilmenau\">PTA-Adhoc: Dr. H\u00f6nle AG: Einleitung von Restrukturierungsma\u00dfnahmen bei der Raesch Quarz (Germany) GmbH, Ilmenau<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">23.Aug..2022<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-adhoc-dr-hoenle-ag-norbert-haimerl-wird-vorstandsvorsitzender-der-dr-hoenle-ag\/\" title=\"PTA-Adhoc: Dr. H\u00f6nle AG: Norbert Haimerl wird Vorstandsvorsitzender der Dr. H\u00f6nle AG\">PTA-Adhoc: Dr. H\u00f6nle AG: Norbert Haimerl wird Vorstandsvorsitzender der Dr. H\u00f6nle AG<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">29.Juli.2022<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-adhoc-dr-hoenle-ag-dr-hoenle-ag-erzielt-betriebsergebnis-von-72-mio-e-im-9-monatszeitraum\/\" title=\"PTA-Adhoc: Dr. H\u00f6nle AG: Dr. H\u00f6nle AG erzielt Betriebsergebnis von 7,2 Mio. \u20ac im 9-Monatszeitraum\">PTA-Adhoc: Dr. H\u00f6nle AG: Dr. H\u00f6nle AG erzielt Betriebsergebnis von 7,2 Mio. \u20ac im 9-Monatszeitraum<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">22.Juli.2022<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-adhoc-dr-hoenle-ag-dr-hoenle-ag-passt-ausblick-fuer-geschaeftsjahr-2021-2022-an\/\" title=\"PTA-Adhoc: Dr. H\u00f6nle AG: Dr. H\u00f6nle AG passt Ausblick f\u00fcr Gesch\u00e4ftsjahr 2021\/2022 an\">PTA-Adhoc: Dr. H\u00f6nle AG: Dr. H\u00f6nle AG passt Ausblick f\u00fcr Gesch\u00e4ftsjahr 2021\/2022 an<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">18.Feb..2022<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-adhoc-dr-hoenle-ag-dr-hoenle-ag-konkretisiert-jahresprognose\/\" title=\"PTA-Adhoc: Dr. H\u00f6nle AG: Dr. H\u00f6nle AG konkretisiert Jahresprognose\">PTA-Adhoc: Dr. H\u00f6nle AG: Dr. H\u00f6nle AG konkretisiert Jahresprognose<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">01.Dez..2021<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-adhoc-dr-hoenle-ag-hoenle-gruppe-erwirtschaftet-bereinigtes-betriebsergebnis-von-79-mio-euro\/\" title=\"PTA-Adhoc: Dr. H\u00f6nle AG: H\u00f6nle Gruppe erwirtschaftet bereinigtes Betriebsergebnis von 7,9 Mio. Euro\">PTA-Adhoc: Dr. H\u00f6nle AG: H\u00f6nle Gruppe erwirtschaftet bereinigtes Betriebsergebnis von 7,9 Mio. Euro<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">24.Nov..2021<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-adhoc-dr-hoenle-ag-hoenle-beruecksichtigt-nicht-zahlungswirksame-wertminderung-im-geschaeftsjahr-2020-2021-ausblick-weiterhin-positiv\/\" title=\"PTA-Adhoc: Dr. H\u00f6nle AG: H\u00f6nle ber\u00fccksichtigt nicht zahlungswirksame Wertminderung im Gesch\u00e4ftsjahr 2020\/2021 \u2013 Ausblick weiterhin positiv\">PTA-Adhoc: Dr. H\u00f6nle AG: H\u00f6nle ber\u00fccksichtigt nicht zahlungswirksame Wertminderung im Gesch\u00e4ftsjahr 2020\/2021 \u2013 Ausblick weiterhin positiv<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">06.Okt..2021<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-adhoc-dr-hoenle-ag-hoenle-passt-ausblick-fuer-abgelaufenes-geschaeftsjahr-an-und-gibt-ausblick-fuer-neues-geschaeftsjahr\/\" title=\"PTA-Adhoc: Dr. H\u00f6nle AG: H\u00f6nle passt Ausblick f\u00fcr abgelaufenes Gesch\u00e4ftsjahr an und gibt Ausblick f\u00fcr neues Gesch\u00e4ftsjahr\">PTA-Adhoc: Dr. H\u00f6nle AG: H\u00f6nle passt Ausblick f\u00fcr abgelaufenes Gesch\u00e4ftsjahr an und gibt Ausblick f\u00fcr neues Gesch\u00e4ftsjahr<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">15.Juli.2021<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-adhoc-dr-hoenle-ag-foerderung-mobiler-luftentkeimungsgeraete-bietet-starke-wachstumschancen-fuer-hoenle\/\" title=\"PTA-Adhoc: Dr. H\u00f6nle AG: F\u00f6rderung mobiler Luftentkeimungsger\u00e4te bietet starke Wachstumschancen f\u00fcr H\u00f6nle\">PTA-Adhoc: Dr. H\u00f6nle AG: F\u00f6rderung mobiler Luftentkeimungsger\u00e4te bietet starke Wachstumschancen f\u00fcr H\u00f6nle<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">15.Sep..2020<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-adhoc-dr-hoenle-ag-dr-hoenle-ag-erwirbt-uv-technik-meyer-gmbh\/\" title=\"PTA-Adhoc: Dr. H\u00f6nle AG: Dr. H\u00f6nle AG erwirbt UV-Technik Meyer GmbH\">PTA-Adhoc: Dr. H\u00f6nle AG: Dr. H\u00f6nle AG erwirbt UV-Technik Meyer GmbH<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">21.Aug..2020<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-adhoc-dr-hoenle-ag-dr-hoenle-ag-gewinnt-neuen-strategischen-investor-zur-wachstumsfinanzierung\/\" title=\"PTA-Adhoc: Dr. H\u00f6nle AG: Dr. H\u00f6nle AG gewinnt neuen strategischen Investor zur Wachstumsfinanzierung\">PTA-Adhoc: Dr. H\u00f6nle AG: Dr. H\u00f6nle AG gewinnt neuen strategischen Investor zur Wachstumsfinanzierung<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">17.Aug..2020<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-adhoc-dr-hoenle-ag-hoenle-uebernimmt-entkeimungsspezialisten-sterilsystems\/\" title=\"PTA-Adhoc: Dr. H\u00f6nle AG: H\u00f6nle \u00fcbernimmt Entkeimungsspezialisten STERILSYSTEMS\">PTA-Adhoc: Dr. H\u00f6nle AG: H\u00f6nle \u00fcbernimmt Entkeimungsspezialisten STERILSYSTEMS<\/a>\n              <\/li>\n                          <li class=\"ir-press-links__item\">\n                <span class=\"ir-press-links__date\">27.Apr..2020<\/span>\n                <a class=\"ir-press-links__link\" href=\"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/pta-adhoc-dr-hoenle-ag-hoenle-zieht-prognose-aufgrund-der-covid-19-pandemie-zurueck\/\" title=\"PTA-Adhoc: Dr. H\u00f6nle AG: H\u00f6nle zieht Prognose aufgrund der Covid-19 Pandemie zur\u00fcck\">PTA-Adhoc: Dr. H\u00f6nle AG: H\u00f6nle zieht Prognose aufgrund der Covid-19 Pandemie zur\u00fcck<\/a>\n              <\/li>\n                             <\/ul>\n      <\/div>\n    <\/div>\n  <\/div>\n<\/div>\n[\/vc_column_inner][\/vc_row_inner]<\/div>            <\/div>\n\n            <!-- Bottom Navigation -->\n                            <div class=\"akt-tabs__bottom-nav\">\n                    <div class=\"akt-tabs__bottom-nav-content\">\n                        <div class=\"akt-tabs__bottom-nav-buttons\">\n                            <button class=\"akt-tabs__nav-button akt-tabs__nav-button--prev\" \n                                    aria-label=\"Previous tab\"\n                                    data-prev-title=\"\"\n                                    disabled>\n                                <span class=\"akt-tabs__nav-button-icon\">\u2039<\/span>\n                                <span class=\"akt-tabs__nav-button-text\"><\/span>\n                            <\/button>\n                            <div class=\"akt-tabs__counter\" aria-live=\"polite\" aria-atomic=\"true\">\n                                1\/2                            <\/div>\n                            \n                            <button class=\"akt-tabs__nav-button akt-tabs__nav-button--next\" \n                                    aria-label=\"Next tab\"\n                                    data-next-title=\"Ad-Hoc-Mitteilung\"\n                                    >\n                                <span class=\"akt-tabs__nav-button-text\">Ad-Hoc-Mitteilung<\/span>\n                                <span class=\"akt-tabs__nav-button-icon\">\u203a<\/span>\n                            <\/button>\n                        <\/div>\n                    <\/div>\n                <\/div>\n                    <\/div>\n        \n    <\/div>\n\n[\/vc_column][\/vc_row][\/vc_section]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_section css=&#8221;.vc_custom_1752143461288{background-color: #F2F4F6 !important;}&#8221;][vc_row][vc_column width=&#8221;1\/2&#8243;][\/vc_column][vc_column width=&#8221;1\/2&#8243;][vc_column_text css=&#8221;&#8221;]Auf dieser Seite finden Sie aktuelle Kapitalmarktmitteilungen und Ad-hoc-Meldungen der Hoenle AG.[\/vc_column_text][\/vc_column][\/vc_row][\/vc_section][vc_section css=&#8221;.vc_custom_1753711788721{background-color: #FFFFFF [&hellip;]<\/p>\n","protected":false},"author":16,"featured_media":0,"parent":5940,"menu_order":8,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"site-sidebar-layout":"no-sidebar","site-content-layout":"plain-container","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-5993","page","type-page","status-publish","hentry"],"rankMath":{"parentDomain":"akt-digital.de","noFollowDomains":[],"noFollowExcludeDomains":[],"noFollowExternalLinks":false,"featuredImageNotice":"Das angezeigte Beitragsbild sollte mindestens 200x200 px gro\u00df sein, damit Facebook und andere Social-Media-Websites es \u00fcbernehmen.","pluginReviewed":false,"postSettings":{"linkSuggestions":false,"useFocusKeyword":false},"frontEndScore":false,"postName":"pta-adhoc-dr-hoenle-ag-hoenle-zieht-prognose-aufgrund-der-covid-19-pandemie-zurueck","permalinkFormat":"https:\/\/hoenle25.akt-digital.de\/de\/press-article\/%ir_press_item%\/","showLockModifiedDate":true,"assessor":{"focusKeywordLink":"https:\/\/hoenle25.akt-digital.de\/wp-admin\/edit.php?focus_keyword=%focus_keyword%&post_type=%post_type%","hasTOCPlugin":false,"primaryTaxonomy":false,"serpData":{"title":"","description":"","focusKeywords":"","pillarContent":false,"canonicalUrl":"","breadcrumbTitle":"","advancedRobots":[],"facebookTitle":"","facebookDescription":"","facebookImage":"","facebookImageID":"","facebookHasOverlay":false,"facebookImageOverlay":"","facebookAuthor":"","twitterCardType":"","twitterUseFacebook":true,"twitterTitle":"","twitterDescription":"","twitterImage":"","twitterImageID":"","twitterHasOverlay":false,"twitterImageOverlay":"","twitterPlayerUrl":"","twitterPlayerSize":"","twitterPlayerStream":"","twitterPlayerStreamCtype":"","twitterAppDescription":"","twitterAppIphoneName":"","twitterAppIphoneID":"","twitterAppIphoneUrl":"","twitterAppIpadName":"","twitterAppIpadID":"","twitterAppIpadUrl":"","twitterAppGoogleplayName":"","twitterAppGoogleplayID":"","twitterAppGoogleplayUrl":"","twitterAppCountry":"","robots":{"index":true},"twitterAuthor":"Benutzername","primaryTerm":0,"authorName":"aktd-dev","titleTemplate":"%title% %sep% %sitename%","descriptionTemplate":"","showScoreFrontend":true,"lockModifiedDate":false},"powerWords":["abgelenkt","abgesturzt","absolut","abstossend","aburd","abweisen","adaquat","aggressiv","ahnungslos","akkurat","alarmierend","alarmiert","albtraum","all-inclusive","allererste","allererster","allererstes","alleswisser","am schlechtesten","am wichtigsten","angewidert","angriff","angsteinflossend","angstlich","animiert","ankundigung","anonym","anpassbar","anspruchslos","anstossig","antagonistisch","apokalypse","applaus","argumentativ","arm","armageddon","arrogant","atemberaubend","attacke","attraktiv","aufdeckend","aufgebracht","aufgedeckt","aufgeregt","aufheiternd","aufregend","aufregende","aufregenden","aufregung","aufstachelnd","aufstandisch","aufsteigend","auftreibend","augenoffnend","ausgelassen","ausgeruht","ausgespielt","ausgewahlt","ausgewuhlt","ausnutzen","aussergewohnlich","autark","authentisch","autoritat","backdoor","badass","beangstigend","bedenklich","bedingungslos","bedrohen","bedroht","beforderung","befreit","befriedigend","befriedigt","begehren","begeistern","begeistert","begeisterung","beherzt","behind the scenes","beichte","beleidigung","belohnung","bemerkenswert","beneiden","bequem","beruhmt","beschadigen","beschamend","beschmutzt","beschuldigen","beschutzen","besitz","bessesen","bestatigen","bestatigt","beste","bestimmt","bestrafen","betrug","betrugen","bewahrt","bewiesen","bewiesenermassen","bewusst","bezahlbar","bezaubernd","bizarre","bleich","blendend","blut","blutbad","blutig","bombe","bonanza","bonus","bosartig","bose","boshaft","brilliant","brodelnd","brutal","budget","bullshit","bully","bunt","bunte","bunten","case study","cash","challenge","challgene","chaos","cheat-sheet","clever","content","cool","courage","dankbar","daruber redet keiner","deadline","definitiv","dekadent","demoralisierend","demut","desillusioniert","detailiert","diagnose","die wahrheit","direkt","disastros","discount","dokument","dollar","dominieren","doppelt","download","dreckig","dreifach","dreistigkeit","dringend","dringlichkeit","dumm","dummkopf","dummlich","durchbruch","duselig","dynamik","echt","effektiv","effizient","ehrlich","eier","eifersuchtig","eifrig","eindeutig","eindrucksvoll","eine stufe besser","einfach","einfachheit","einfallsreich","eingebildet","eingeschrankt","eingesperrt","einmalig","einsam","eintauchen","einzigartig","eisern","eliminieren","elite","empathie","empfehle","empfehlen","endeffekt","energie","energisch","enorm","entdecken","entfesselt","entfremdet","enthullen","enthullung","enthusiastisch","entmachtet","entsetzlich","entspannt","entzuckend","entzunden","epidemisch","episch","erbarmlich","erfolg","erfolgreich","erfolgsbilanz","erfreut","erfullen","erfullt","ergebnisse","ergreifen","erhaben","erheben","erhohen","erledigt","ermachtigt","ermudet","ernmutigt","ernsthaft","erobern","erroten","errungenschaft","erschaffen","erschrocken","ersehnen","ersparnisse","erstattbar","erstatten","erstaunlich","erste","ertrinken","essentiell","ethisch","euphorisch","exakt","exklusiv","exklusivitat","exkuisit","experte","explodieren","explosiv","exposed","extrem","exzellent","fahig","fahigkeiten","fail","falle","fantasie","fantastischen","farbenfroh","farbenfrohe","faszinierend","faszinierende","faul","faux pas","faux","fehler","feindselig","feldstudie","fesselnd","festlich","festmahl","festplatte","final","flirt","fluchtling","flussig","fokus","fokussiert","folter","formel","frech","freebie","frei","freiheit","freudig","friedlich","frohlich","frohlichkeit","frustriert","fundamental","fur immer","furchtbar","furchtlos","gangster","garantiert","geblendet","geehrt","gefahr","gefahrlich","gefangen","gefangnis","gefeuert","gegensatzlich","gehassig","geheimnis","geheimnisse","geil","geisseln","geist","geistesgestort","gelassen","geld zuruck","geld","genial","gepackt","gerade angekommen","gerissen","geschenk","geschmuggelt","geschutzt","gestandnis","gestandnisse","gestopft","gestresst","gesucht","gesund","getauscht","getestet","getotet","gewaltig","gewalttatig","gewidmet","gewinnspiel","gier","gierig","gift","giftig","gigantisch","giveaway","glamourose","glanzend","glaube","glaubwurdig","gleichmassig","glittering","glitzernde","gluckselig","golden","grandios","grandiose","grandiosen","grandioses","grauenhaft","grausamkeit","grinsen","groesste","gross","grossartig","grossartig","grossartige","grossartigen","grossartiger","grossartiges","grosse","grossen","grosste","grosszugig","grotesk","grube","grundlegend","gruselig","gunstig","hack","hamisch","hammer","handelsgeheimnis","hartnackig","hass","heilig","heimlich","heisshunger","heisshungrig","heiter","held","hell","herablassend","herausfordernd","herausforderung","herausvorderung","herrlichen","herrschend","hervorragend","herz","herzbrechend","herzerwahrmend","heute","hightech","hilflosigkeit","hilfreich","hilfsbereit","himmlisch","hinterhaltig","hoax","hocheffektiv","hochnasig","hochste","hoffnung","hoffnungsvoll","holle","holocaust","horror","how to","humor","hungrige","hurrikan","hypnotisch","hypnotisierend","idiot","idiotisch","illegal","immer","informativ","inhalt","inkompetent","innovativ","insider","inspirierend","inspiriert","intelligent","intensiv","interessant","interessante","invasion","investment","ist da","jackpot","jederzeit kundigen","jetzt","jubilant","jumpstart","jung","kadaver","kampf","katapult","katastrophe","kaufen","kein risiko","keine verpflichtung","kickstart","kindisch","kitschig","klaglich","klar","knast","kollabieren","kollosal","komfortabel","komisch","kompetitiv","komplett","kompromiss","komsich","konstruktiv","kontrollierend","kontrollverlust","kooperativ","kopie","korrupt","kostenlos","kraftlos","kraftvoll","krankhaft","kreativ","kreative","kriese","kritisch","kruppel","lachen","lacherlich","lahm","last minute","lauernd","lebendig","lebenslanglich","lecken","lecker","legendar","legitim","leiche","leicht","leiden","leider","leise","letzte chance","letzte","leuchtend","liberal","licht","liebe","liebenswurdig","liebevoll","life-changing","limitiert","lohnend","loser","losung","lugen","lugend","lukrativ","lust","lustig","lustige","lustigsten","luxorios","magisch","mainstream","mammut","manipulativ","massiv","masterclass","meditierend","meiseter","meistverkauft","meltdown","millionen","mind-blowing","minderwertig","minimalist","missbrauch","misstrauisch","mittelmassig","mittig","modern","moderne","moglichkeiten","monetarisieren","monumental","mord","motiviert","muhelos","muhevoll","mull","mut","mutig","nachmachen","nachteile","nackt","nagel","naiv","natural","nazi","neid","nervos","neu","niedertrachtig","niemals","notfall","notiert","nutzlich","nutzlos","offensichtlich","offiziel","offnen","ohne hintergedanken","ok","okay","okonomisch","on-demand","opfer","optimistisch","overnight","packend","panik","panzer","paralisiert","pas","passioniert","pause","payback","peinlich","perfekt","perplex","perskeptive","pessimistisch","pfund","piranha","pleite","plotzlich","pochend","polarisierend","popular","portfolio","praktisch","preis","prestige","privat","privatsphare","priviligiert","problem","produktiv","professionell","profit","profitabel","provokativ","provozierend","prozess","psychologisch","qual","qualen","qualitat","rabatt","rache","rachsuchtig","raffiniert","rasend","rat","rau","recherche","reduziert","reflektieren","regeln","reich","reiche","reichtum","relaxed","report","responsive","revolutionar","riesig","risiko","riskant","riskieren","rotzfrech","rowdy","ruckrat","ruckschlag","rucksichtlos","ruhig","ruiniert","sabotiert","sadistisch","sale","sarkastisch","scam","schabig","schadigend","schadlich","schamlos","schatz","schicksal","schlachten","schlafen","schlag","schlau","schlimm","schmerzhaft","schmerzlos","schmuggel","schnell","schnellstart","schokierend","schonheit","schrecklich","schreien","schritt fur schritt","schuld","schuldlos","schwach","schwarm","schwarzmarkt","schwerkraft","schwinden","sechsstellig","sehenswerte","selbsthass","selten","sensationell","sex","sexy","sicher","sicherheit","sicherlich","sieg","sill","simpel","sinnlich","sinnlos","skandal","skandalos","skill","sklave","sneak-peek","snob","sofort gespart","sofort","sollte","sonnig","sonnige","sonnigen","sorgen","sorgfaltig","sorglos","spannend","sparen","sparsam","spass","spassig","spektakular","speziell","spielen","spoiler","spontan","spotlight","stabil","stark","start","stoisch","stolz","stop","strahlend","strangulieren","strategie","studien","stumperhaft","stur","sunden","sundigend","super","superb","survival","tapfer","tauschend","teaser","technologie","terror","terrorist","teuer","tief","tiefgreifend","tierisch","tod","todlich","toll","tolle","toller","tortur","tot","tote","toten","totend","toxisch","tragisch","tragodie","transfomieren","transparenz","trauma","traumatisiert","traurigkeit","trend","tricks","trigger","triumpf","trocken","trotz","trugerisch","tweaks","tyrann","ubel","uberfordert","uberkommen","uberleben","uberlegen","uberraschend","uberrascht","uberraschung","uberwaltigend","uberwinden","ultimativ","umfassend","umstritten","umwerfend","unatorisiert","unaufhaltbar","unausgelasted","unbedacht","unbeliebt","unbeschwert","unbewusst","undercover","undokumentiert","unehrlich","unentschlossen","unerwartet","unfahig","ungeduldig","ungedult","ungehort","ungemutlich","ungerechtfertigt","ungesehen","ungetrubt","ungewohnlich","ungezogen","unglaublich","unglaubliches","uninteressiert","unkontrollierbar","unkonventionell","unlimitiert","unpenetrierbar","unschuldig","unsicher","unstabil","unter verschluss","untergrund","unterhaltsam","unterstutz","unterstutzend","unubertroffen","unvergesslich","unverneinbar","unvoreingenommen","unwiderstehlich","unwirtlich","unzensiert","unzuverlassig","up-selling","vaporisieren","verangstigt","verantwortlich","verargert","verarscht","verbessert","verbluffend","verblufft","verboten","verbreiten","verdachtig","verdammt","verdeckt","vereinfacht","verfuhrend","vergebend","vergessen","vergleich","verhauen","verifizieren","verkommen","verlegen","verletzbar","verletzt","verlockend","verloren","vermasselt","vermeiden","vermogen","vernichten","vernichtend","vernunftig","veroffentlichung","verpassen","verraterisch","verruckt","versagen","verschwitzt","versichert","verspielt","versprechend","versteckt","vertrauenswurdig","vertraulich","vertraumt","verurteilend","verwunderlich","verwundet","verzaubernd","verzweifelt","vierfach","vogelfrei","vollig","vollstandig","vorsicht","vorstellungskraft","vorteil","wachstum","wagemutig","wahnsinn","wahnsinnig","wahrhaftig","wahrheit","wahrheitsgemass","wahrscheinlich","warnung","was dir keiner sagt","wehleidig","welt","wenig bekannt","wert","wertvoll","wichtig","widerlich","wiedererkannt","wild","wilde","wilden","willensstarke","wirr","wohltatigkeit","wortlich","wunder","wunderbar","wunderbaren","wunderschon","wutend","zeichen","zeitig","zen","zensiert","zerschlagen","zerschmetternd","zerstorend","zertifiziert","zielorientiert","zischend","zischt","zocken","zogernd","zugeben","zuruckgehalten","zuruckgelassen","zuruckweisen","zusatzlich","zutaten","zuverlassig","zwangsernahrt","zweifelnd","zwickend","zwingend","einfache","einfachen","einfaches","einfacher","simple","simplen","simples","simpler","besten","bestes","bester","beste","bestbewertet","bestbewerteten","bestbewertete","bestbewerteter","bestbewertetes","\u00fcberraschende","\u00fcberraschenden","\u00fcberraschendes","\u00fcberraschender","hilfreiche","hilfreiches","hilfreichen","hilfreicher","f\u00f6rdern","unterst\u00fctzen","helfen","spielerisch","spannende","spannendes","spannenden","spannender","gro\u00dfartige","gro\u00dfartiges","gro\u00dfartigen","gro\u00dfartiger","ideal","ideales","idealen","idealer","faszinierend","faszinierendes","faszinierenden","faszinierender","wichtig","wichtige","wichtiges","wichtigen","wichtiger","sicher","sichere","sicheres","sicheren","sicherer","umfassende","umfassendes","umfassenden","umfassender","ultimative","ultimatives","ultimativen","ultimativer","einzigartige","einzigartiges","einzigartigen","einzigartiger"],"diacritics":{"A":"[\\u0041\\u24B6\\uFF21\\u00C0\\u00C1\\u00C2\\u1EA6\\u1EA4\\u1EAA\\u1EA8\\u00C3\\u0100\\u0102\\u1EB0\\u1EAE\\u1EB4\\u1EB2\\u0226\\u01E0\\u01DE\\u1EA2\\u00C5\\u01FA\\u01CD\\u0200\\u0202\\u1EA0\\u1EAC\\u1EB6\\u1E00\\u0104\\u023A\\u2C6F]","AA":"[\\uA732]","AE":"[\\u00C6\\u01FC\\u01E2\\u00C4]","AO":"[\\uA734]","AU":"[\\uA736]","AV":"[\\uA738\\uA73A]","AY":"[\\uA73C]","B":"[\\u0042\\u24B7\\uFF22\\u1E02\\u1E04\\u1E06\\u0243\\u0182\\u0181]","C":"[\\u0043\\u24B8\\uFF23\\u0106\\u0108\\u010A\\u010C\\u00C7\\u1E08\\u0187\\u023B\\uA73E]","D":"[\\u0044\\u24B9\\uFF24\\u1E0A\\u010E\\u1E0C\\u1E10\\u1E12\\u1E0E\\u0110\\u018B\\u018A\\u0189\\uA779]","DZ":"[\\u01F1\\u01C4]","Dz":"[\\u01F2\\u01C5]","E":"[\\u0045\\u24BA\\uFF25\\u00C8\\u00C9\\u00CA\\u1EC0\\u1EBE\\u1EC4\\u1EC2\\u1EBC\\u0112\\u1E14\\u1E16\\u0114\\u0116\\u00CB\\u1EBA\\u011A\\u0204\\u0206\\u1EB8\\u1EC6\\u0228\\u1E1C\\u0118\\u1E18\\u1E1A\\u0190\\u018E]","F":"[\\u0046\\u24BB\\uFF26\\u1E1E\\u0191\\uA77B]","G":"[\\u0047\\u24BC\\uFF27\\u01F4\\u011C\\u1E20\\u011E\\u0120\\u01E6\\u0122\\u01E4\\u0193\\uA7A0\\uA77D\\uA77E]","H":"[\\u0048\\u24BD\\uFF28\\u0124\\u1E22\\u1E26\\u021E\\u1E24\\u1E28\\u1E2A\\u0126\\u2C67\\u2C75\\uA78D]","I":"[\\u0049\\u24BE\\uFF29\\u00CC\\u00CD\\u00CE\\u0128\\u012A\\u012C\\u0130\\u00CF\\u1E2E\\u1EC8\\u01CF\\u0208\\u020A\\u1ECA\\u012E\\u1E2C\\u0197]","J":"[\\u004A\\u24BF\\uFF2A\\u0134\\u0248]","K":"[\\u004B\\u24C0\\uFF2B\\u1E30\\u01E8\\u1E32\\u0136\\u1E34\\u0198\\u2C69\\uA740\\uA742\\uA744\\uA7A2]","L":"[\\u004C\\u24C1\\uFF2C\\u013F\\u0139\\u013D\\u1E36\\u1E38\\u013B\\u1E3C\\u1E3A\\u0141\\u023D\\u2C62\\u2C60\\uA748\\uA746\\uA780]","LJ":"[\\u01C7]","Lj":"[\\u01C8]","M":"[\\u004D\\u24C2\\uFF2D\\u1E3E\\u1E40\\u1E42\\u2C6E\\u019C]","N":"[\\u004E\\u24C3\\uFF2E\\u01F8\\u0143\\u00D1\\u1E44\\u0147\\u1E46\\u0145\\u1E4A\\u1E48\\u0220\\u019D\\uA790\\uA7A4]","NJ":"[\\u01CA]","Nj":"[\\u01CB]","O":"[\\u004F\\u24C4\\uFF2F\\u00D2\\u00D3\\u00D4\\u1ED2\\u1ED0\\u1ED6\\u1ED4\\u00D5\\u1E4C\\u022C\\u1E4E\\u014C\\u1E50\\u1E52\\u014E\\u022E\\u0230\\u022A\\u1ECE\\u0150\\u01D1\\u020C\\u020E\\u01A0\\u1EDC\\u1EDA\\u1EE0\\u1EDE\\u1EE2\\u1ECC\\u1ED8\\u01EA\\u01EC\\u00D8\\u01FE\\u0186\\u019F\\uA74A\\uA74C]","OE":"[\\u00D6]","OI":"[\\u01A2]","OO":"[\\uA74E]","OU":"[\\u0222]","P":"[\\u0050\\u24C5\\uFF30\\u1E54\\u1E56\\u01A4\\u2C63\\uA750\\uA752\\uA754]","Q":"[\\u0051\\u24C6\\uFF31\\uA756\\uA758\\u024A]","R":"[\\u0052\\u24C7\\uFF32\\u0154\\u1E58\\u0158\\u0210\\u0212\\u1E5A\\u1E5C\\u0156\\u1E5E\\u024C\\u2C64\\uA75A\\uA7A6\\uA782]","S":"[\\u0053\\u24C8\\uFF33\\u1E9E\\u015A\\u1E64\\u015C\\u1E60\\u0160\\u1E66\\u1E62\\u1E68\\u0218\\u015E\\u2C7E\\uA7A8\\uA784]","T":"[\\u0054\\u24C9\\uFF34\\u1E6A\\u0164\\u1E6C\\u021A\\u0162\\u1E70\\u1E6E\\u0166\\u01AC\\u01AE\\u023E\\uA786]","TZ":"[\\uA728]","U":"[\\u0055\\u24CA\\uFF35\\u00D9\\u00DA\\u00DB\\u0168\\u1E78\\u016A\\u1E7A\\u016C\\u01DB\\u01D7\\u01D5\\u01D9\\u1EE6\\u016E\\u0170\\u01D3\\u0214\\u0216\\u01AF\\u1EEA\\u1EE8\\u1EEE\\u1EEC\\u1EF0\\u1EE4\\u1E72\\u0172\\u1E76\\u1E74\\u0244]","UE":"[\\u00DC]","V":"[\\u0056\\u24CB\\uFF36\\u1E7C\\u1E7E\\u01B2\\uA75E\\u0245]","VY":"[\\uA760]","W":"[\\u0057\\u24CC\\uFF37\\u1E80\\u1E82\\u0174\\u1E86\\u1E84\\u1E88\\u2C72]","X":"[\\u0058\\u24CD\\uFF38\\u1E8A\\u1E8C]","Y":"[\\u0059\\u24CE\\uFF39\\u1EF2\\u00DD\\u0176\\u1EF8\\u0232\\u1E8E\\u0178\\u1EF6\\u1EF4\\u01B3\\u024E\\u1EFE]","Z":"[\\u005A\\u24CF\\uFF3A\\u0179\\u1E90\\u017B\\u017D\\u1E92\\u1E94\\u01B5\\u0224\\u2C7F\\u2C6B\\uA762]","a":"[\\u0061\\u24D0\\uFF41\\u1E9A\\u00E0\\u00E1\\u00E2\\u1EA7\\u1EA5\\u1EAB\\u1EA9\\u00E3\\u0101\\u0103\\u1EB1\\u1EAF\\u1EB5\\u1EB3\\u0227\\u01E1\\u01DF\\u1EA3\\u00E5\\u01FB\\u01CE\\u0201\\u0203\\u1EA1\\u1EAD\\u1EB7\\u1E01\\u0105\\u2C65\\u0250]","aa":"[\\uA733]","ae":"[\\u00E6\\u01FD\\u01E3\\u00E4]","ao":"[\\uA735]","au":"[\\uA737]","av":"[\\uA739\\uA73B]","ay":"[\\uA73D]","b":"[\\u0062\\u24D1\\uFF42\\u1E03\\u1E05\\u1E07\\u0180\\u0183\\u0253]","c":"[\\u0063\\u24D2\\uFF43\\u0107\\u0109\\u010B\\u010D\\u00E7\\u1E09\\u0188\\u023C\\uA73F\\u2184]","d":"[\\u0064\\u24D3\\uFF44\\u1E0B\\u010F\\u1E0D\\u1E11\\u1E13\\u1E0F\\u0111\\u018C\\u0256\\u0257\\uA77A]","dz":"[\\u01F3\\u01C6]","e":"[\\u0065\\u24D4\\uFF45\\u00E8\\u00E9\\u00EA\\u1EC1\\u1EBF\\u1EC5\\u1EC3\\u1EBD\\u0113\\u1E15\\u1E17\\u0115\\u0117\\u00EB\\u1EBB\\u011B\\u0205\\u0207\\u1EB9\\u1EC7\\u0229\\u1E1D\\u0119\\u1E19\\u1E1B\\u0247\\u025B\\u01DD]","f":"[\\u0066\\u24D5\\uFF46\\u1E1F\\u0192\\uA77C]","g":"[\\u0067\\u24D6\\uFF47\\u01F5\\u011D\\u1E21\\u011F\\u0121\\u01E7\\u0123\\u01E5\\u0260\\uA7A1\\u1D79\\uA77F]","h":"[\\u0068\\u24D7\\uFF48\\u0125\\u1E23\\u1E27\\u021F\\u1E25\\u1E29\\u1E2B\\u1E96\\u0127\\u2C68\\u2C76\\u0265]","hv":"[\\u0195]","i":"[\\u0069\\u24D8\\uFF49\\u00EC\\u00ED\\u00EE\\u0129\\u012B\\u012D\\u00EF\\u1E2F\\u1EC9\\u01D0\\u0209\\u020B\\u1ECB\\u012F\\u1E2D\\u0268\\u0131]","j":"[\\u006A\\u24D9\\uFF4A\\u0135\\u01F0\\u0249]","k":"[\\u006B\\u24DA\\uFF4B\\u1E31\\u01E9\\u1E33\\u0137\\u1E35\\u0199\\u2C6A\\uA741\\uA743\\uA745\\uA7A3]","l":"[\\u006C\\u24DB\\uFF4C\\u0140\\u013A\\u013E\\u1E37\\u1E39\\u013C\\u1E3D\\u1E3B\\u017F\\u0142\\u019A\\u026B\\u2C61\\uA749\\uA781\\uA747]","lj":"[\\u01C9]","m":"[\\u006D\\u24DC\\uFF4D\\u1E3F\\u1E41\\u1E43\\u0271\\u026F]","n":"[\\u006E\\u24DD\\uFF4E\\u01F9\\u0144\\u00F1\\u1E45\\u0148\\u1E47\\u0146\\u1E4B\\u1E49\\u019E\\u0272\\u0149\\uA791\\uA7A5]","nj":"[\\u01CC]","o":"[\\u006F\\u24DE\\uFF4F\\u00F2\\u00F3\\u00F4\\u1ED3\\u1ED1\\u1ED7\\u1ED5\\u00F5\\u1E4D\\u022D\\u1E4F\\u014D\\u1E51\\u1E53\\u014F\\u022F\\u0231\\u022B\\u1ECF\\u0151\\u01D2\\u020D\\u020F\\u01A1\\u1EDD\\u1EDB\\u1EE1\\u1EDF\\u1EE3\\u1ECD\\u1ED9\\u01EB\\u01ED\\u00F8\\u01FF\\u0254\\uA74B\\uA74D\\u0275]","oe":"[\\u00f6]","oi":"[\\u01A3]","ou":"[\\u0223]","oo":"[\\uA74F]","p":"[\\u0070\\u24DF\\uFF50\\u1E55\\u1E57\\u01A5\\u1D7D\\uA751\\uA753\\uA755]","q":"[\\u0071\\u24E0\\uFF51\\u024B\\uA757\\uA759]","r":"[\\u0072\\u24E1\\uFF52\\u0155\\u1E59\\u0159\\u0211\\u0213\\u1E5B\\u1E5D\\u0157\\u1E5F\\u024D\\u027D\\uA75B\\uA7A7\\uA783]","s":"[\\u0073\\u24E2\\uFF53\\u015B\\u1E65\\u015D\\u1E61\\u0161\\u1E67\\u1E63\\u1E69\\u0219\\u015F\\u023F\\uA7A9\\uA785\\u1E9B]","ss":"[\\u00DF]","t":"[\\u0074\\u24E3\\uFF54\\u1E6B\\u1E97\\u0165\\u1E6D\\u021B\\u0163\\u1E71\\u1E6F\\u0167\\u01AD\\u0288\\u2C66\\uA787]","tz":"[\\uA729]","u":"[\\u0075\\u24E4\\uFF55\\u00F9\\u00FA\\u00FB\\u0169\\u1E79\\u016B\\u1E7B\\u016D\\u01DC\\u01D8\\u01D6\\u01DA\\u1EE7\\u016F\\u0171\\u01D4\\u0215\\u0217\\u01B0\\u1EEB\\u1EE9\\u1EEF\\u1EED\\u1EF1\\u1EE5\\u1E73\\u0173\\u1E77\\u1E75\\u0289]","ue":"[\\u00FC]","v":"[\\u0076\\u24E5\\uFF56\\u1E7D\\u1E7F\\u028B\\uA75F\\u028C]","vy":"[\\uA761]","w":"[\\u0077\\u24E6\\uFF57\\u1E81\\u1E83\\u0175\\u1E87\\u1E85\\u1E98\\u1E89\\u2C73]","x":"[\\u0078\\u24E7\\uFF58\\u1E8B\\u1E8D]","y":"[\\u0079\\u24E8\\uFF59\\u1EF3\\u00FD\\u0177\\u1EF9\\u0233\\u1E8F\\u00FF\\u1EF7\\u1E99\\u1EF5\\u01B4\\u024F\\u1EFF]","z":"[\\u007A\\u24E9\\uFF5A\\u017A\\u1E91\\u017C\\u017E\\u1E93\\u1E95\\u01B6\\u0225\\u0240\\u2C6C\\uA763]"},"researchesTests":["contentHasTOC","contentHasShortParagraphs","contentHasAssets","keywordInTitle","keywordInMetaDescription","keywordInPermalink","keywordIn10Percent","keywordInContent","keywordInSubheadings","keywordInImageAlt","keywordDensity","keywordNotUsed","lengthContent","lengthPermalink","linksHasInternal","linksHasExternals","linksNotAllExternals","titleStartWithKeyword","titleSentiment","titleHasPowerWords","titleHasNumber","hasContentAI"],"hasRedirection":false,"hasBreadcrumb":true},"homeUrl":"https:\/\/hoenle25.akt-digital.de\/de\/","objectID":20951,"objectType":"post","locale":"de","localeFull":"de_DE","overlayImages":{"play":{"name":"Wiedergabezeichen","url":"https:\/\/hoenle25.akt-digital.de\/wp-content\/plugins\/seo-by-rank-math\/assets\/admin\/img\/icon-play.png","path":"\/var\/www\/hoenle\/wp-content\/plugins\/seo-by-rank-math\/assets\/admin\/img\/icon-play.png","position":"middle_center"},"gif":{"name":"GIF-Symbol","url":"https:\/\/hoenle25.akt-digital.de\/wp-content\/plugins\/seo-by-rank-math\/assets\/admin\/img\/icon-gif.png","path":"\/var\/www\/hoenle\/wp-content\/plugins\/seo-by-rank-math\/assets\/admin\/img\/icon-gif.png","position":"middle_center"}},"defautOgImage":"https:\/\/hoenle25.akt-digital.de\/wp-content\/plugins\/seo-by-rank-math\/assets\/admin\/img\/social-placeholder.jpg","customPermalinks":true,"isUserRegistered":false,"autoSuggestKeywords":false,"connectSiteUrl":"https:\/\/rankmath.com\/auth?site=https%3A%2F%2Fhoenle25.akt-digital.de%2Fde%2F&r=https%3A%2F%2Fhoenle25.akt-digital.de%2Fde%2Fwp-json%2Fwp%2Fv2%2Fpages%2F5993%3Fnonce%3Dcf8bd28afd","maxTags":5,"trendsIcon":"<svg viewBox=\"0 0 610 610\"><path d=\"M18.85,446,174.32,290.48l58.08,58.08L76.93,504a14.54,14.54,0,0,1-20.55,0L18.83,466.48a14.54,14.54,0,0,1,0-20.55Z\" style=\"fill:#4285f4\"\/><path d=\"M242.65,242.66,377.59,377.6l-47.75,47.75a14.54,14.54,0,0,1-20.55,0L174.37,290.43l47.75-47.75A14.52,14.52,0,0,1,242.65,242.66Z\" style=\"fill:#ea4335\"\/><polygon points=\"319.53 319.53 479.26 159.8 537.34 217.88 377.61 377.62 319.53 319.53\" style=\"fill:#fabb05\"\/><path d=\"M594.26,262.73V118.61h0a16.94,16.94,0,0,0-16.94-16.94H433.2a16.94,16.94,0,0,0-12,28.92L565.34,274.71h0a16.94,16.94,0,0,0,28.92-12Z\" style=\"fill:#34a853\"\/><rect width=\"610\" height=\"610\" style=\"fill:none\"\/><\/svg>","showScore":true,"siteFavIcon":"https:\/\/hoenle25.akt-digital.de\/wp-content\/uploads\/cropped-web-app-manifest-512x512-1-150x150.png","canUser":{"general":false,"advanced":false,"snippet":false,"social":false,"analysis":false,"analytics":false,"content_ai":false},"showKeywordIntent":true,"isPro":false,"is_front_page":false,"trendsUpgradeLink":"https:\/\/rankmath.com\/pricing\/?utm_source=Plugin&utm_medium=CE%20General%20Tab%20Trends&utm_campaign=WP","trendsUpgradeLabel":"Upgraden","trendsPreviewImage":"https:\/\/hoenle25.akt-digital.de\/wp-content\/plugins\/seo-by-rank-math\/assets\/admin\/img\/trends-preview.jpg","currentEditor":false,"homepageData":{"assessor":{"powerWords":["abgelenkt","abgesturzt","absolut","abstossend","aburd","abweisen","adaquat","aggressiv","ahnungslos","akkurat","alarmierend","alarmiert","albtraum","all-inclusive","allererste","allererster","allererstes","alleswisser","am schlechtesten","am wichtigsten","angewidert","angriff","angsteinflossend","angstlich","animiert","ankundigung","anonym","anpassbar","anspruchslos","anstossig","antagonistisch","apokalypse","applaus","argumentativ","arm","armageddon","arrogant","atemberaubend","attacke","attraktiv","aufdeckend","aufgebracht","aufgedeckt","aufgeregt","aufheiternd","aufregend","aufregende","aufregenden","aufregung","aufstachelnd","aufstandisch","aufsteigend","auftreibend","augenoffnend","ausgelassen","ausgeruht","ausgespielt","ausgewahlt","ausgewuhlt","ausnutzen","aussergewohnlich","autark","authentisch","autoritat","backdoor","badass","beangstigend","bedenklich","bedingungslos","bedrohen","bedroht","beforderung","befreit","befriedigend","befriedigt","begehren","begeistern","begeistert","begeisterung","beherzt","behind the scenes","beichte","beleidigung","belohnung","bemerkenswert","beneiden","bequem","beruhmt","beschadigen","beschamend","beschmutzt","beschuldigen","beschutzen","besitz","bessesen","bestatigen","bestatigt","beste","bestimmt","bestrafen","betrug","betrugen","bewahrt","bewiesen","bewiesenermassen","bewusst","bezahlbar","bezaubernd","bizarre","bleich","blendend","blut","blutbad","blutig","bombe","bonanza","bonus","bosartig","bose","boshaft","brilliant","brodelnd","brutal","budget","bullshit","bully","bunt","bunte","bunten","case study","cash","challenge","challgene","chaos","cheat-sheet","clever","content","cool","courage","dankbar","daruber redet keiner","deadline","definitiv","dekadent","demoralisierend","demut","desillusioniert","detailiert","diagnose","die wahrheit","direkt","disastros","discount","dokument","dollar","dominieren","doppelt","download","dreckig","dreifach","dreistigkeit","dringend","dringlichkeit","dumm","dummkopf","dummlich","durchbruch","duselig","dynamik","echt","effektiv","effizient","ehrlich","eier","eifersuchtig","eifrig","eindeutig","eindrucksvoll","eine stufe besser","einfach","einfachheit","einfallsreich","eingebildet","eingeschrankt","eingesperrt","einmalig","einsam","eintauchen","einzigartig","eisern","eliminieren","elite","empathie","empfehle","empfehlen","endeffekt","energie","energisch","enorm","entdecken","entfesselt","entfremdet","enthullen","enthullung","enthusiastisch","entmachtet","entsetzlich","entspannt","entzuckend","entzunden","epidemisch","episch","erbarmlich","erfolg","erfolgreich","erfolgsbilanz","erfreut","erfullen","erfullt","ergebnisse","ergreifen","erhaben","erheben","erhohen","erledigt","ermachtigt","ermudet","ernmutigt","ernsthaft","erobern","erroten","errungenschaft","erschaffen","erschrocken","ersehnen","ersparnisse","erstattbar","erstatten","erstaunlich","erste","ertrinken","essentiell","ethisch","euphorisch","exakt","exklusiv","exklusivitat","exkuisit","experte","explodieren","explosiv","exposed","extrem","exzellent","fahig","fahigkeiten","fail","falle","fantasie","fantastischen","farbenfroh","farbenfrohe","faszinierend","faszinierende","faul","faux pas","faux","fehler","feindselig","feldstudie","fesselnd","festlich","festmahl","festplatte","final","flirt","fluchtling","flussig","fokus","fokussiert","folter","formel","frech","freebie","frei","freiheit","freudig","friedlich","frohlich","frohlichkeit","frustriert","fundamental","fur immer","furchtbar","furchtlos","gangster","garantiert","geblendet","geehrt","gefahr","gefahrlich","gefangen","gefangnis","gefeuert","gegensatzlich","gehassig","geheimnis","geheimnisse","geil","geisseln","geist","geistesgestort","gelassen","geld zuruck","geld","genial","gepackt","gerade angekommen","gerissen","geschenk","geschmuggelt","geschutzt","gestandnis","gestandnisse","gestopft","gestresst","gesucht","gesund","getauscht","getestet","getotet","gewaltig","gewalttatig","gewidmet","gewinnspiel","gier","gierig","gift","giftig","gigantisch","giveaway","glamourose","glanzend","glaube","glaubwurdig","gleichmassig","glittering","glitzernde","gluckselig","golden","grandios","grandiose","grandiosen","grandioses","grauenhaft","grausamkeit","grinsen","groesste","gross","grossartig","grossartig","grossartige","grossartigen","grossartiger","grossartiges","grosse","grossen","grosste","grosszugig","grotesk","grube","grundlegend","gruselig","gunstig","hack","hamisch","hammer","handelsgeheimnis","hartnackig","hass","heilig","heimlich","heisshunger","heisshungrig","heiter","held","hell","herablassend","herausfordernd","herausforderung","herausvorderung","herrlichen","herrschend","hervorragend","herz","herzbrechend","herzerwahrmend","heute","hightech","hilflosigkeit","hilfreich","hilfsbereit","himmlisch","hinterhaltig","hoax","hocheffektiv","hochnasig","hochste","hoffnung","hoffnungsvoll","holle","holocaust","horror","how to","humor","hungrige","hurrikan","hypnotisch","hypnotisierend","idiot","idiotisch","illegal","immer","informativ","inhalt","inkompetent","innovativ","insider","inspirierend","inspiriert","intelligent","intensiv","interessant","interessante","invasion","investment","ist da","jackpot","jederzeit kundigen","jetzt","jubilant","jumpstart","jung","kadaver","kampf","katapult","katastrophe","kaufen","kein risiko","keine verpflichtung","kickstart","kindisch","kitschig","klaglich","klar","knast","kollabieren","kollosal","komfortabel","komisch","kompetitiv","komplett","kompromiss","komsich","konstruktiv","kontrollierend","kontrollverlust","kooperativ","kopie","korrupt","kostenlos","kraftlos","kraftvoll","krankhaft","kreativ","kreative","kriese","kritisch","kruppel","lachen","lacherlich","lahm","last minute","lauernd","lebendig","lebenslanglich","lecken","lecker","legendar","legitim","leiche","leicht","leiden","leider","leise","letzte chance","letzte","leuchtend","liberal","licht","liebe","liebenswurdig","liebevoll","life-changing","limitiert","lohnend","loser","losung","lugen","lugend","lukrativ","lust","lustig","lustige","lustigsten","luxorios","magisch","mainstream","mammut","manipulativ","massiv","masterclass","meditierend","meiseter","meistverkauft","meltdown","millionen","mind-blowing","minderwertig","minimalist","missbrauch","misstrauisch","mittelmassig","mittig","modern","moderne","moglichkeiten","monetarisieren","monumental","mord","motiviert","muhelos","muhevoll","mull","mut","mutig","nachmachen","nachteile","nackt","nagel","naiv","natural","nazi","neid","nervos","neu","niedertrachtig","niemals","notfall","notiert","nutzlich","nutzlos","offensichtlich","offiziel","offnen","ohne hintergedanken","ok","okay","okonomisch","on-demand","opfer","optimistisch","overnight","packend","panik","panzer","paralisiert","pas","passioniert","pause","payback","peinlich","perfekt","perplex","perskeptive","pessimistisch","pfund","piranha","pleite","plotzlich","pochend","polarisierend","popular","portfolio","praktisch","preis","prestige","privat","privatsphare","priviligiert","problem","produktiv","professionell","profit","profitabel","provokativ","provozierend","prozess","psychologisch","qual","qualen","qualitat","rabatt","rache","rachsuchtig","raffiniert","rasend","rat","rau","recherche","reduziert","reflektieren","regeln","reich","reiche","reichtum","relaxed","report","responsive","revolutionar","riesig","risiko","riskant","riskieren","rotzfrech","rowdy","ruckrat","ruckschlag","rucksichtlos","ruhig","ruiniert","sabotiert","sadistisch","sale","sarkastisch","scam","schabig","schadigend","schadlich","schamlos","schatz","schicksal","schlachten","schlafen","schlag","schlau","schlimm","schmerzhaft","schmerzlos","schmuggel","schnell","schnellstart","schokierend","schonheit","schrecklich","schreien","schritt fur schritt","schuld","schuldlos","schwach","schwarm","schwarzmarkt","schwerkraft","schwinden","sechsstellig","sehenswerte","selbsthass","selten","sensationell","sex","sexy","sicher","sicherheit","sicherlich","sieg","sill","simpel","sinnlich","sinnlos","skandal","skandalos","skill","sklave","sneak-peek","snob","sofort gespart","sofort","sollte","sonnig","sonnige","sonnigen","sorgen","sorgfaltig","sorglos","spannend","sparen","sparsam","spass","spassig","spektakular","speziell","spielen","spoiler","spontan","spotlight","stabil","stark","start","stoisch","stolz","stop","strahlend","strangulieren","strategie","studien","stumperhaft","stur","sunden","sundigend","super","superb","survival","tapfer","tauschend","teaser","technologie","terror","terrorist","teuer","tief","tiefgreifend","tierisch","tod","todlich","toll","tolle","toller","tortur","tot","tote","toten","totend","toxisch","tragisch","tragodie","transfomieren","transparenz","trauma","traumatisiert","traurigkeit","trend","tricks","trigger","triumpf","trocken","trotz","trugerisch","tweaks","tyrann","ubel","uberfordert","uberkommen","uberleben","uberlegen","uberraschend","uberrascht","uberraschung","uberwaltigend","uberwinden","ultimativ","umfassend","umstritten","umwerfend","unatorisiert","unaufhaltbar","unausgelasted","unbedacht","unbeliebt","unbeschwert","unbewusst","undercover","undokumentiert","unehrlich","unentschlossen","unerwartet","unfahig","ungeduldig","ungedult","ungehort","ungemutlich","ungerechtfertigt","ungesehen","ungetrubt","ungewohnlich","ungezogen","unglaublich","unglaubliches","uninteressiert","unkontrollierbar","unkonventionell","unlimitiert","unpenetrierbar","unschuldig","unsicher","unstabil","unter verschluss","untergrund","unterhaltsam","unterstutz","unterstutzend","unubertroffen","unvergesslich","unverneinbar","unvoreingenommen","unwiderstehlich","unwirtlich","unzensiert","unzuverlassig","up-selling","vaporisieren","verangstigt","verantwortlich","verargert","verarscht","verbessert","verbluffend","verblufft","verboten","verbreiten","verdachtig","verdammt","verdeckt","vereinfacht","verfuhrend","vergebend","vergessen","vergleich","verhauen","verifizieren","verkommen","verlegen","verletzbar","verletzt","verlockend","verloren","vermasselt","vermeiden","vermogen","vernichten","vernichtend","vernunftig","veroffentlichung","verpassen","verraterisch","verruckt","versagen","verschwitzt","versichert","verspielt","versprechend","versteckt","vertrauenswurdig","vertraulich","vertraumt","verurteilend","verwunderlich","verwundet","verzaubernd","verzweifelt","vierfach","vogelfrei","vollig","vollstandig","vorsicht","vorstellungskraft","vorteil","wachstum","wagemutig","wahnsinn","wahnsinnig","wahrhaftig","wahrheit","wahrheitsgemass","wahrscheinlich","warnung","was dir keiner sagt","wehleidig","welt","wenig bekannt","wert","wertvoll","wichtig","widerlich","wiedererkannt","wild","wilde","wilden","willensstarke","wirr","wohltatigkeit","wortlich","wunder","wunderbar","wunderbaren","wunderschon","wutend","zeichen","zeitig","zen","zensiert","zerschlagen","zerschmetternd","zerstorend","zertifiziert","zielorientiert","zischend","zischt","zocken","zogernd","zugeben","zuruckgehalten","zuruckgelassen","zuruckweisen","zusatzlich","zutaten","zuverlassig","zwangsernahrt","zweifelnd","zwickend","zwingend","einfache","einfachen","einfaches","einfacher","simple","simplen","simples","simpler","besten","bestes","bester","beste","bestbewertet","bestbewerteten","bestbewertete","bestbewerteter","bestbewertetes","\u00fcberraschende","\u00fcberraschenden","\u00fcberraschendes","\u00fcberraschender","hilfreiche","hilfreiches","hilfreichen","hilfreicher","f\u00f6rdern","unterst\u00fctzen","helfen","spielerisch","spannende","spannendes","spannenden","spannender","gro\u00dfartige","gro\u00dfartiges","gro\u00dfartigen","gro\u00dfartiger","ideal","ideales","idealen","idealer","faszinierend","faszinierendes","faszinierenden","faszinierender","wichtig","wichtige","wichtiges","wichtigen","wichtiger","sicher","sichere","sicheres","sicheren","sicherer","umfassende","umfassendes","umfassenden","umfassender","ultimative","ultimatives","ultimativen","ultimativer","einzigartige","einzigartiges","einzigartigen","einzigartiger"],"diacritics":true,"researchesTests":["contentHasTOC","contentHasShortParagraphs","contentHasAssets","keywordInTitle","keywordInMetaDescription","keywordInPermalink","keywordIn10Percent","keywordInContent","keywordInSubheadings","keywordInImageAlt","keywordDensity","keywordNotUsed","lengthContent","lengthPermalink","linksHasInternal","linksHasExternals","linksNotAllExternals","titleStartWithKeyword","titleSentiment","titleHasPowerWords","titleHasNumber","hasContentAI"],"hasBreadcrumb":true,"serpData":{"title":"%sitename% %page% %sep% %sitedesc%","description":"","titleTemplate":"%sitename% %page% %sep% %sitedesc%","descriptionTemplate":"","focusKeywords":"","breadcrumbTitle":"Home","robots":{"index":true},"advancedRobots":[],"facebookTitle":"","facebookDescription":"","facebookImage":"","facebookImageID":""}}},"tocTitle":"Table of Contents","tocExcludeHeadings":[],"listStyle":"ul"},"_links":{"self":[{"href":"https:\/\/hoenle25.akt-digital.de\/de\/wp-json\/wp\/v2\/pages\/5993","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hoenle25.akt-digital.de\/de\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/hoenle25.akt-digital.de\/de\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/hoenle25.akt-digital.de\/de\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/hoenle25.akt-digital.de\/de\/wp-json\/wp\/v2\/comments?post=5993"}],"version-history":[{"count":15,"href":"https:\/\/hoenle25.akt-digital.de\/de\/wp-json\/wp\/v2\/pages\/5993\/revisions"}],"predecessor-version":[{"id":22039,"href":"https:\/\/hoenle25.akt-digital.de\/de\/wp-json\/wp\/v2\/pages\/5993\/revisions\/22039"}],"up":[{"embeddable":true,"href":"https:\/\/hoenle25.akt-digital.de\/de\/wp-json\/wp\/v2\/pages\/5940"}],"wp:attachment":[{"href":"https:\/\/hoenle25.akt-digital.de\/de\/wp-json\/wp\/v2\/media?parent=5993"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}